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1
FØTALE OG PERINATALE KONSEKVENSER AV UTVIKLINGSAVVIK I 
FORDØYELSESKANALEN OG I BUKVEGGEN  
 
Studien tar for seg tilstandene gastroschise og omfalocele, som er forskjellige former for 
bukveggsdefekter samt utviklingsavvik som gir forsnevringer på ulike nivå i 
fordøyelseskanalen: spiserør (øsofagusobstruksjon), tolvfingertarm (duodenalobstruksjon) 
og endetarm (imperforert anus). Nyfødte med disse tilstandene trenger snarlig kirurgisk 
behandling. Diagnostisering før fødsel, ved hjelp av ultralyd, gir mulighet for optimalisert 
overvåking og omsorg både under svangerskapet og i forbindelse med fødsel, noe som kan 
forbedre prognosen for disse barna. Behandlingen av fostre med medfødte utviklingsavvik 
har tradisjonelt vært bygd på kunnskap om fødte individer. Vi har hatt mangelfull 
kunnskap om den betydningen utviklingsavvik har for fosteret – både i løpet av 
svangerskapet og i tiden rundt fødselen. 
 
Nøyaktigheten av de prenatale diagnosene var stor for alle de undersøkte tilstandene. I den 
ikke-selekterte populasjonen var oppdagelsesraten høy for tilfeller med gastroschise 
(100%), omfalocele (95%) og duodenalobstruksjon (82%), mens oppdagelsesraten for 
øsofagusobstruksjon var relativt lav (43%), og for imperforert anus veldig lav (11%). Alle 
disse diagnosene var betydelig vanligere i vår studiepopulasjon som inkluderte fostre, 
sammenliknet med tidligere beskrevet forekomst blant nyfødte. Fosterpopulasjoner er 
dermed forskjellige fra nyfødtpopulasjoner og har flere utviklingsavvik.  
 
Fostre med gastroschise eller duodenalobstruksjon har økt risiko for fosterdød og bør 
overvåkes nøye i slutten av svangerskapet. 
 
Gastroschise 
64 fostre ble fulgt fra diagnosetidspunkt, som var 19. svangerskapsuke i gjennomsnitt. Alle 
hadde normale kromosomer, 6% hadde andre utviklingsavvik i tillegg. Tegn på utvidelse 
av den del av tarmen som lå inni fosterets buk var assosiert med obstruksjon av tarmen. I 
tidligere studier er det beskrevet fosterdød hos ca 10-15% av fostre med gastroschise, men 
i denne studien var det bare ett foster som døde. Tegn på fosterstress som gjorde akutt 
keisersnitt nødvendig, oppstod hos 22%. Fostre med gastroschise har økt risiko for å 
utvikle fosterstress, med fosterdød som ytterste konsekvens, og de bør derfor overvåkes 
nøye med hyppige CTG-registreringer de siste ukene for fødsel. 
 
Omfalocele 
90 fostre ble fulgt fra diagnosetidspunkt (18. svangerskapsuke). Omfalocelene ble delt inn i 
ulike typer basert på plasseringen: epigastriske, sentrale og hypogastriske. Kromosomfeil 
(oftest trisomi 18) forekom hos 69% av fostrene med sentralt omfalocele, sammenliknet 
med 13% hos de med epigastrisk omfalocele. Dette kan tyde på at sentrale og epigastriske 
omfaloceler er to helt forskjellige tilstander. 89% hadde assosierte, til dels dødelige avvik, 
og dermed ble resultatene dårlige. Bare 8 (9%) overlevde og var friske. I overvåkingen av 
fostre med omfalocele bør en fokusere på de tilfellene hvor prognosen kan tenkes å være 
god. 
 
Duodenalobstruksjon 
29 fostre ble fulgt fra gjennomsnittlig diagnosetidspunkt i 29. svangerskapsuke. 21% hadde 
trisomi 21 (Down syndrom). Totalt hadde 62% assosierte avvik. Isolert 
duodenalobstruksjon med et forventet godt resultat forekom hos 11 (38%) fostre. Likevel 
døde 5 av disse før fødselen, eller de ble født med betydelige nevrologiske 
symptomer/skader som medførte varige funksjonshemninger – sannsynligvis på grunn av 
oksygenmangel. Vår hypotese er at utvidelse av nedre del av spiserøret kan påvirke 
fosterets hjerterytme og medføre hjertestans og død. Fostre med duodenalobstruksjon har 
økt risiko for dårlig utkomme. Siden fosterdød synes å inntreffe akutt, kan det være 
vanskelig å overvåke disse fostrene, men de bør følges nøye i slutten av svangerskapet og 
en bør vurdere forløsning før termin. 
 
Imperforert anus 
Av 69 fostre med imperforert anus var det bare 16% som fikk diagnosen før fødselen. 
Kromosomfeil forekom hos 13%. Assosierte avvik var hyppige (86%), og imperforert anus 
var ofte en del av ulike syndromer. Resultatet var dårlig, med bare 35% overlevelse. Ved 
isolert imperforert anus eller bare én ekstra anomali var overlevelsen 94% sammenliknet 
med bare 14% for de med flere anomalier. Oppdagelsesraten før fødsel kan nok forbedres 
framover, men enkelte tilfeller med imperforert anus vil aldri kunne diagnostiseres før 
fødsel. 
 
Øsofagusobstruksjon 
Hos 48 fostre med øsofagusobstruksjon var oppdagelsesraten før fødsel 44%. Unormalt 
stor fostervannsmengde og symptomer som følge av dette førte til diagnostisering. Dermed 
ble diagnosen stilt sent (32 uker). 23% hadde kromosomfeil og totalt hadde 79% assosierte 
avvik. Overlevelsen var høyere, men ikke signifikant høyere, for dem som hadde isolert 
øsofagusobstruksjon og for dem som fikk diagnosen før fødsel. Økt bevissthet om 
muligheten for øsofagusobstruksjon, som kan føre til en målrettet undersøkelse, bør kunne 
forbedre den framtidige diagnostikken.  
 
Målene med studiene. Materiale og metoder  
Målet med studiene var å beskrive resultatene fra tidspunktet for prenatal diagnose, 
gjennom svangerskap og fødsel og inn i nyfødtperioden. Dessuten var målet å identifisere 
risikofaktorer og bestemme hvorvidt overvåking kan bedre utfallet. Et annet mål var å 
finne ut hvor stor andel som fikk diagnosen før fødsel, og å kartlegge mulighetene for 
forbedret diagnostisering. 
 
Alle studiene var basert på en selektert populasjon som bestod av henviste pasienter i 
tillegg til vår egen ikke-selekterte populasjon. Den ikke-selekterte populasjonen ble 
dessuten undersøkt separat. Fostrene med gastroschise, omfalocele og duodenalobstruksjon 
ble i den selekterte populasjonen fulgt fra tidspunktet for prenatal diagnose. Diagnosene 
øsofagusobstruksjon og imperforert anus i den selekterte populasjonen ble stilt enten før 
eller etter fødselen og populasjonen inkluderte alle som hadde gjennomgått minst én 
ultralydundersøkelse. 
 
Anne Brantberg 
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INTRODUCTION 
 
Background 
Congenital anomalies occur in approximately 3% of all infants (Kalter and Warkany 
1983), and about 90% occur in fetuses born to parents with no recognizable risk factor. 
Fetal anomalies are a leading cause of premature years of life lost and contribute to a high 
rate of all nations’ chronic disease burden (Oakley 1986). In the United States, congenital 
malformations were the leading cause of infant mortality in the 1990’s (Lee et al. 2001). 
Fetal examinations by ultrasound during pregnancy provide the possibility to detect 
anomalies prenatally and thereby present an opportunity to optimize the care for the 
various conditions including treatment, surveillance and the planning of the mode, time 
and place of delivery. Fetal examinations also provide important information needed in 
counseling parents. If the fetus has a lethal or serious condition, a prenatal diagnosis 
gives the parents an option to terminate the pregnancy. Prenatal diagnosis may also 
prevent unnecessary cesarean sections (de la Vega and Verdiales 2001) and aid in 
counseling for future pregnancies (Boyd et al. 2004). 
 
Congenital anomalies present diagnostic challenges in fetal medicine. First and foremost 
an accurate and high prenatal detection rate of the main anomalies is crucial. Many 
anomalies are accompanied by lethal associated conditions, thus the ability to recognize 
or to exclude the presence of possible associated anomalies and conditions that may 
affect the outcome is also crucial. In the beginning of the ultrasound era, many were 
concerned about the accuracy of prenatal diagnosis and whether it could lead to 
termination of pregnancies with healthy fetuses that had falsely been thought to have an 
anomaly. “False positive cases”, and the ethics regarding prenatal diagnosis were heavily 
debated. There is now, however, research that shows a good correlation between prenatal 
diagnoses and postmortem findings (Isaksen et al. 1998; Isaksen et al. 1999; Isaksen et 
al. 2000; Stiller et al. 2001; Wald et al. 2004).  
 
Traditionally, the outcome of infants with congenital anomalies has been based on 
available data registered from newborns. However, because of the great differences 
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between neonatal and fetal populations, information gleaned from a neonatal population 
may be misleading regarding surveillance and treatment. It is also inappropriate in our 
counseling of parents who are interested in the prognosis for their fetuses at the time of 
the diagnosis, not only the prognosis from the time after birth. In our efforts to refine 
intrauterine surveillance, treatment and knowledge about prognoses, we must focus on 
natural intrauterine development of certain anomalies throughout pregnancy. This 
knowledge may help us. However, to obtain the knowledge of intrauterine development 
of certain anomalies we need large populations, centralized institutions with a high 
frequency of anomalies, accurate pre- and postnatal examinations as well as accurate 
pathological examinations. The registration and follow-up must be meticulous.  
 
Many gastrointestinal anomalies and abdominal wall defects can be repaired with 
surgery. Historically, there have been several attempts to correct a number of anomalies 
but it was not until the 1940’s, when incubators were invented and neonatal intensive care 
became a specialized profession, that the attempts resulted in improved survival for more 
than a few isolated cases. Infants with gastrointestinal tract anomalies and abdominal wall 
defects need early neonatal surgery and will benefit from delivery at a specialist center 
with appropriate neonatal facilities. A prenatal diagnosis of anomalies in the 
gastrointestinal tract and abdominal wall gives several advantages. For example, it 
provides important information that aids us in counseling and preparing the parents for 
the postnatal surgery and treatment (Hancock and Wiseman 1989). The possibility to 
survey the fetuses appropriately may reduce the risk for intrauterine fetal death (IUFD). 
In addition, prenatal diagnosis makes it possible to plan the mode and time of delivery 
and to transport the fetus in utero to the appropriate medical unit. By optimizing the 
conditions, the perinatal morbidity and mortality may be reduced. A reduction in 
morbidity has been shown in fetuses with prenatally diagnosed gastroschisis and 
intestinal obstruction (Romero et al. 1988; Saari-Kemppainen et al. 1994; Bittencourt et 
al. 2004). Improvement of the outcome over years for fetuses with duodenal obstruction 
has also been reported (Murshed et al. 1999). This improvement most likely represents a 
combination of better surgical techniques, improved neonatal intensive care and 
anesthesia, and increased numbers of prenatally diagnosed cases.  
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History of congenital anomalies 
Hippokrates (460 - 370 B.C.), known as the father of western medicine, emphasized the 
importance of observing the natural course of diseases. He believed that the natural 
course had to be studied to be able to improve the knowledge of the etiology, treatment 
and prevention of diseases. Based on this knowledge it would be possible to diagnose 
(dia:through, gnosis:knowledge) and thereby establish a prognosis for various conditions 
(Lindegård and Åström 1989). This is the foundation for evidence-based medicine. 
Historical descriptions of conditions may, in this context, improve our knowledge and 
evidence.  
 
Figure 1  
Reprint from The Edwin Smith Surgical Papyrus by Breasted (Breasted 1930). 
 
 
“Smith Surgical Papyrus”, transcribed in the years 3000 to 2500 B.C., contains the first 
written anatomic, physiologic, clinical and pathologic observation recorded by man 
(Breasted 1930; Brewer 1980). All cases in the Smith papyrus were classified as (1) “an 
ailment which I will treat” (believed curable), (2) “an ailment which I will contend” 
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(possibly curable), or (3) “an ailment which will not be treated” (incurable). The surgical 
treatise is mostly a series of discussions of injuries, not of diseases. The papyrus includes 
a case (Case 28) with “A gaping wound in the throat penetrating to the gullet” and this 
may be the first description of an esophageal injury (Breasted 1930) (Figure 1). 
 
Esophageal obstruction 
The first report of an esophageal anomaly was made in 1670 when Durston (Durston 
1670-1671) described a blind-ending upper esophagus in one of a pair of female 
thoracopagus conjoined twins. A classic esophageal atresia with distal tracheo-
esophageal fistula was first described and documented by Thomas Gibson in 1697 (Spitz 
2006). In 1840, Thomas Hill reported a case with esophageal atresia in connection with 
imperforate anus (Hill 1840). He tried to perform anorectal surgery on the case, which is 
referred to as the first attempt to perform “posterior sagittal anorectal procedure”. The 
first attempt to operate on a case with esophageal atresia was made by Charles Steele in 
1888 (Steele 1888). Scientific discoveries at the end of the 19th century made solid 
abdominal surgery possible. Thoracic surgery followed in the 20th century, with rapid 
strides during World War II. These wartime advances stimulated an interest in esophageal 
surgery in the postwar era (Brewer 1980). Various surgeons made several attempts to 
operate on esophageal atresia during the 1930’s and 1940’s. The first survivors were 
operated on with staged reconstruction in 1939 and were independently reported by 
Leven (Leven 1941) and Ladd (Ladd 1944). Two years later, in 1941, Haight and 
Towsley performed the first successful primary repair of an esophageal atresia (Haight 
and Towsley 1943), a method that is still used. Prenatal suspicion/diagnosis of 
esophageal atresia by ultrasound was reported in 2 cases in 1982 (Jassani et al. 1982).  
 
Duodenal obstruction 
In 1808, Aubéry described a case of duodenal obstruction (Aubéry 1808), which probably 
was the first known description. About a century later, Cordes presented (Cordes 1901) a 
detailed description of all 57 cases of duodenal obstruction known at that time. In 1914, 
Ernst performed the first successful duodeno-jejunostomy on an infant with duodenal 
atresia (Ernst 1916). The surgical techniques were discussed and evaluated during the 
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beginning of the 20th century and Webb and Wangenstein concluded, in 1931, that all 
cases that had survived so far had undergone surgery with anastomotic procedure, while 
none of the cases recovered after enterostomy had been performed (Webb and 
Wangenstein 1931). The current surgical procedure of choice is commonly 
duodenoduodenostomy (Murshed et al. 1999; Escobar et al. 2004). The prenatal 
appearance by ultrasound in a case with duodenal atresia was reported already in 1975 
(Loveday et al. 1975). 
 
Imperforate anus 
A successful operation for imperforate anus was described in the seventh century by 
Paulus of Ægineta in Greece in his famous “Medical Compendium in Seven Books” 
(“Epitomes iatrikes biblio hepta”) (Ægineta, translated 1844). According to Bradham 
(Bradham and Charleston 1958), a case of congenital anal stenosis was successfully 
dilated with gentian roots in 1640 and the first perineal dissection was performed in 1787. 
Campbell performed a successful operation for imperforate anus in 1790 (Bradham and 
Charleston 1958). In 1835, Amussat (Amussat 1835) recommended proctoplasty by 
careful dissection of the perineum, mobilization of the rectum, and suture of the rectum 
and anal site. Nowadays, the posterior sagittal approach is the surgical method of choice 
(Pena 1995), however, careful evaluation is necessary (Pena and Hong 2000). The first 
prenatal description of a case with imperforate anus was presented in 1978 (Bean et al. 
1978).  
 
Abdominal wall defects  
In 1733, Calder described a case with gastroschisis, and in the same paper, another case 
with duodenal duplication and solid pylorus (Calder 1733). His description of the 
gastroschisis case is interesting:  
The child seemed otherwise to be as lively and brisk as any newborn infant 
uses to be, and for 12 or 14 hours it received milk and syrups by the 
mouth, without any appearance of uneasiness; but after that time it 
vomited every thing till its death, which happened four days after, and all 
the while it had no passage by the anus. The guts which were inflated, and 
had no peristaltic motion that I could observe, gradually inflamed, and 
before the child died, were become perfectly black (Calder 1733).  
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This description of the condition also included a thorough description of the gastroschisis, 
an autopsy report and a maternal history. Calder’s paper emphasizes the value of 
thorough case reports, which may be read with interest 270 years later. In 1878, Fear 
described another true case of gastroschisis including a successful repair (Fear 1878).  
 
In 1894, Taruffi subclassified “gastroschisis” into seven categories according to location 
and content: A. Epi-gastro-schisi (aperture in the epigastric region), B. Epi-omphalo-
schisi (aperture in the epigastrium in continuation with the umbilicus), C. Thoraco-
omphalo-schisi (umbilical aperture continued into the sternum), D. Ipo-gastro-schisi 
(aperture in hypogastrium), E. Pleurosomo-schisi (lateral aperture of the trunk), F. 
Ipogastro-etro-schisi (aperture of the hypogastric region, including the symphysis pubis), 
G. Olo-gastro-etro-schisi (aperture of the whole abdomen, extending to the symphysis 
pubis) (Taruffi 1894a). Taruffi’s description of “gastroschisis” included all known 
varieties of abdominal wall defects including gastroschisis and omphalocele. In addition, 
his book contained a description of “omphalocele”, including umbilical hernias and 
omphaloceles (Taruffi 1894b). In 1904, Ballantyne also used the term “gastroschisis” for 
all abdominal wall defects but, in contrast to Taruffi, preferred to describe extroversion of 
the bladder by itself (Ballantyne 1904). Ballantyne discussed the problems of 
nomenclature and classification and also indicated that the term exomphalos 
(omphalocele) focuses attention on the umbilicus and should not be used as synonomous 
with gastroschisis. Ballantyne cited Lycosthenes’ Chronicon of 1557 as the earliest 
recorded case of “gastroschisis”, a case from 1547. However, according to the 
nomenclature used today, this probably was a case of limb body-wall complex. 
Lycosthenes’ description highlights the difficulty of comparing various diagnoses from 
old literature with modern nomenclature and classification of abdominal wall defects. For 
example, thoracoschisis, ectopia cordis, OIES-complex etc. have been incorporated under 
the term of “gastroschisis” (from Greek: gastro – belly; schism – separation/cleft). In 
addition, the diagnoses of limb body-wall complex and amniotic rupture sequence have 
commonly been misdiagnosed as gastroschisis (Pribram 1927) because these diagnoses, 
among a number of anomalies, may include an abdominal wall bowel defect with 
uncovered bowel protruding through the defect. 
 15 
Treatment of gastroschisis was reported in Watkins’ article on an early successful 
surgical repair of a true gastroschisis in 1943 (Watkins 1943). He attributed the success 
of this case to early and frequent rehydration, early repair, the use of prostigmine to 
stimulate peristalsis, and the fact that the case had less disproportion than usual between 
the abdominal cavity and eventrated viscera. In 1951, Moore and Stokes encountered 
their first two cases with “uncovered abdominal wall evisceration of intestine in the 
newborn” (Moore and Stokes 1953; Moore 1977). Still, at this time there was a 
multiplicity of terms applied to anterior abdominal wall defects and it was difficult to 
evaluate the conditions due to the lack of a clear and established classification 
(Kiesewetter 1957). Gastroschisis was the term commonly used for what we today call 
omphalocele (Shaw 1975). In addition, gastroschisis was often considered an 
omphalocele with ruptured sac (Rickham 1963; Hutchin and Goldenberg 1965; Moore 
1977). New surgical techniques for abdominal wall defects were established during the 
1950’s - 60’s and the importance of prompt surgery was emphasized (Cavanagh and 
Welty 1965; Hutchin 1965). In spite of the attention paid to techniques and timing, the 
mortality of infants with gastroschisis was 90% as late as in 1967 (Swift et al. 1992). 
With this in mind, it is easier to understand the following citation from 1985, which 
demonstrates that only 20 years ago gastroschisis was still considered a serious anomaly 
with a high mortality.  
Although one of the cases of gastroschisis was diagnosed at 20 weeks 
sonographically, the parents opted to continue the pregnancy, and their 
neonate had an excellent outcome after surgery. This case illustrates that 
not all of the gastrointestinal abnormalities, severe as they may seem, are 
hopeless and that with neonatal-pediatric surgical expertise, intervention 
can be successful after birth (Barss et al. 1985).  
 
Few other conditions have had the same level of improvement, as has been the case for 
gastroschisis. A fetus with gastroschisis is a classic example of the importance of prenatal 
diagnosis and subsequent transportation of the fetus in utero to the place where delivery and 
postnatal surgery is to be performed. Antenatal diagnosis of gastroschisis by ultrasound was 
reported in 1977 (Lee and Warren 1977). Omphalocele was diagnosed prenatally in 3 fetuses 
in 1978 by Campbell (Campbell et al. 1978) and the same year Schlensker described an 
additional case (Schlensker 1978).  
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Embryology of the gastrointestinal tract and abdominal wall 
The majority of fetal anomalies develop during the embryonic period. Therefore, the 
knowledge of the normal human embryonic development is a prerequisite for the 
understanding of certain anomalies and their association with other conditions/anomalies. 
The purpose of this section is to provide a brief overview of available knowledge and 
research on the embryo and its development.  
 
All statements of gestational age in this chapter are based on last menstrual period and are 
expressed either in completed weeks and days or in measurements of crown rump length 
(CRL). In the early literature of pathology and embryology, the measurements of CRL 
were performed on dead embryos/fetuses, which might have been somewhat different 
than ultrasound measurements of living embryos/fetuses. Since the research is sometimes 
based on age and sometimes on length, the following table (Table 1) is included for ease 
of comparison. 
 
Table 1 
Approximate correlations of CRL (ultrasound measurements) and gestational weeks (Blaas 1999). 
 
Gestational week CRL  
(weeks + days) (mm) 
 5 + 0 - 6 0 - 3  
 6 + 0 - 6 4 - 8  
 7 + 0 - 6 9 - 14  
 8 + 0 - 6 15 - 22  
 9 + 0 - 6  23 - 31  
 10 + 0 - 6  32 - 42  
 11 + 0 - 6  43 - 54  
 
Normal embryology  
The human embryo develops from a unicellular stage through a bilaminar and three-
laminar disc into a cylindrical body. At week 4, the embryo has a bilateral symmetry with 
dorsal and ventral surfaces, rostral and caudal ends and left and right sides. The 
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neurulation starts and the oropharyngeal and cloacal membrane and the primitive heart 
tube appear. The folding process that transforms the embryonic disc into a cylindrical 
body takes place from approximately 4 weeks + 6 days to 5 weeks + 1 day (±1 day). This 
folding process (O'Rahilly and Müller 1987) draws the amniotic membrane, and thus the 
amniotic cavity over the embryo (Figures 2, 3).  
 
Figure 2  
Development during approximately the 5th completed gestational week. Reprinted from “Human 
Embryology and developmental biology”, Bruce M. Carlson, Third edition, 2004, Establishment of the 
basic embryonic body plan, Picture 6-18, Page 121, Mosby Inc (Carlson 2004) with permission from 
Elsevier. 
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Figure 3 
Human embryos showing the relationship of the chorion and extraembryonic membranes. Reprinted from 
“Human Embryology and developmental biology”, Bruce M. Carlson, Third edition, Placenta and 
extraembryonic membranes, Picture 7-1, Page 130, 2004, Mosby Inc (Carlson 2004) with permission from 
Elsevier. 
 
 
 
The amniotic membrane subsequently ensheathes the body stalk or umbilical cord 
(remnants of allantois, umbilical vessels and vitelline duct). The endoderm and the yolk 
sac are in continuity and become incorporated in the embryo as the primitive gut (Lauge-
Hansen 1973). At a CRL of 7 - 8 mm, the gastrointestinal tract shows all its fundamental 
features, with distinct differentiation of its various segments, its mesenteries and its 
viscera (Lauge-Hansen 1973). At a CRL of 7 - 10 mm, the primary bowel loop has been 
described as entering the umbilical cord (Kiesselbach 1952) and at approximately 7 
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weeks and 6 days, the primary intestinal loop can be seen further projecting into the 
umbilical cord (Streeter 1948) and the counterclockwise rotation begins. Meckel reported 
on the development of the embryonic gastrointestinal tract in 1817 and stated that the 
midgut herniation in embryos was physiological (Meckel 1817). A remnant of the 
vitelline duct, called Meckel’s diverticulum, is sometimes found at the ileum. At a CRL 
of 12 mm, the ultimate shape of the stomach is seen (Lauge-Hansen 1973) and at 8 
weeks, the stomach shows the fornix, corpus and pars pylorica (Pernkopf 1923).The 
cloacal membrane ruptures from urinary pressure (Ludwig 1965) and the anal membrane 
breaks down around this time (Ludwig 1965; deVries and Friedland 1974; O'Rahilly 
1978). The subdivision of the cloaca into an anterior primitive urogenital sinus and a 
posterior rectum takes place between 6 - 8 gestational weeks. The urorectal septum that 
divides the cloaca comprises three distinct septae: the Tourneaux fold that initially grows 
inferiorly to the level of the future pelvic urethra, after which the separation is completed 
by the left and right Rathke folds that grow in a coronal plane (Larsen 2001) (Figure 4).  
 
Figure 4 
Subdivision of the cloaca into an anterior primitive urogenital sinus and a posterior rectum (between 
approximately 6 and 8 weeks of gestation). Reprinted with permission from ”Human Embryology”, 
William J. Larsen, 2001, Churchill Livingstone (Larsen 2001). 
 
 
 
The stomach has been found to have a considerable diameter of mean 2.3 mm (in the 
fundus) in transverse section at 9 weeks (Hawass et al. 1991). With ultrasound, the 
stomach can be visualized from 8 weeks and normal diameter values are established from 
8 to 12 gestational weeks (Blaas et al. 1995). The lumen of the esophagus is partially 
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occluded by epithelium by the 8th week and large vacuoles appear (Carlson 2004). At the 
same time, the plugging and vacuolization of the duodenum takes place (Tandler 1902; 
Boyden et al. 1967). This embryonic development concerning the duodenum has been 
discussed and some authors doubt the existence of complete plugging followed by 
vacuolization and recanalization (Moutsouris 1966; Cheng and Tam 1998). During weeks 
10+0 to 11+6, the intestine returns to the abdominal cavity after a rotation of 270º and the 
physiological herniation should be completed after week 11+6 (Kiesselbach 1952; Lauge-
Hansen 1973). The ultrasound appearance of the midgut herniation was first described by 
Cyr in 1986 (Cyr et al. 1986); both its appearance and its size from week 7 - 12 were later 
described by Blaas (Blaas et al. 1995). 
 
 
Figure 5 
Hox gene expression along the developing digestive tract. Expression along the gut endoderm (right) and in 
the gut-associated mesoderm (left). The circles represent areas where sphincters are located. Reprinted from 
“Human Embryology and developmental biology”, Bruce M. Carlson, Third edition, 2004, Digestive and 
respiratory systems and body cavities, Picture 15-1, Page 354, Mosby Inc (Carlson 2004) with permission 
from Elsevier. 
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The fetal gastrointestinal tract arises from different divisions of the embryonic endoderm 
(Gleason et al. 2000). The esophagus, stomach, duodenum, liver and pancreas arise from 
the foregut. The jejunum, ileum, and proximal 2/3 of the colon arise from the midgut and 
the distal colon, rectum and anus from the hindgut. The splanchnic mesoderm is the 
origin of the peritoneal and muscular components of the gastrointestinal tract (Gleason et 
al. 2000). The blood supply of the foregut (lower esophagus to duodenum) is through the 
celiac artery. The superior mesenteric artery supplies the midgut and the inferior 
mesenteric artery the hindgut (Carlson 2004). The gastrointestinal tract develops from a 
simple tube into a complicated digestive system. This development is dependent on the 
amount and concentration of various signal molecules (sonic hedgehog, hox genes, etc.) 
for the determination of the cranio-caudal, left/right and ventro-dorsal development and 
orientation of organs in the embryonic body (Figure 5). 
 
Assumed pathological embryology of the gastrointestinal tract and abdominal wall 
During the early development, abnormal separation of the tracheal bud from the 
esophagus leads to a variety of tracheoesophageal fistulas frequently found in connection 
with stenosis or atresia of the trachea or esophagus (Carlson 2004) (Figure 6).  
 
Figure 6 
In green: the gastrointestinal and respiratory tract and their close relation in embryos at approximately 6 
and 8 gestational weeks, respectively. Reprint from Hinrichsen, Human-Embryologie, (Abbildung 20-23, 
Intestinaltraktus). Klaus V. Hinrichsen, 1990 (Hinrichsen 1990). With kind permission of Springer Science 
and Business Media. 
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A number of genes are important in the normal mesenchymal partition of esophagus and 
trachea. Mutants of some transcription factors and of the sonic hedgehog may result in 
the absence of septation between the trachea and esophagus (Carlson 2004). Is it thought 
that stenosis or atresia of the esophagus is caused by abnormal recanalization of the 
esophagus, as a result of defective growth of endodermal cells, after epithelial occlusion 
of its lumen (Moore and Persaud 2003). 
 
Stenosis and/or atresia of the duodenum is also thought to be caused by failure of 
vacuolization and recanalization following the so-called solid stage of duodenal 
development. This theory was first postulated by Tandler in 1902 (Tandler 1902). 
However, the theory has been questioned on several occasions over the years and is still 
questioned (Cheng and Tam 1998). It has also been suggested that the atretic segment of 
the duodenum is an abnormally situated bile duct (Gourevitch 1971).  
 
Imperforate anus is caused by an abnormal development of the urorectal septum and/or of 
incomplete separation of the cloaca into urogenital and anorectal portions (Larsen 2001; 
Carlson 2004). Imperforate anus can hide a number of underlying conditions such as anal 
and rectal atresias of various lengths with or without fistulas (anoperineal, rectovaginal, 
rectourethral and rectovesical). Imperforate anus is also seen in cloacal anomalies. 
 
The etiology of omphalocele is believed to be a folding defect (Duhamel 1963; Thieme 
1992). The complete embryological development of the various types of omphalocele is 
not yet entirely understood. The process may be complex and the etiology may vary for 
the various types of omphalocele. The timing of the folding process may also play a role. 
Recent studies indicate a central role for epithelial-mesenchymal interactions in ventral 
body wall closure, either in the transition at the umbilicus or in cell-cell communication 
from the ectoderm to the mesoderm of the body wall (Brewer and Williams 2004a; 
Brewer and Williams 2004b).  
 
These new theories may also apply to gastroschisis. Most likely, the etiology for ventral 
body wall defects is complex and includes a number of signal substances and genes. 
Gastroschisis has been believed to be the result of a vascular compromise in the 
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embryonic period. The most favored hypothesis is that there is an interruption in the 
development of the omphalomesenteric artery (Hoyme et al. 1981; Hoyme et al. 1983). 
Another theory is that an abnormal involution of the right umbilical vein may cause a 
weakness in the abdominal wall leading to protrusion of the bowel through that weakness 
(deVries 1980). These hypotheses are questioned in a recent review and a novel 
hypothesis that gastroschisis is a result of abnormal folding is proposed (Feldkamp et al. 
2007). 
 
Epidemiology of anomalies 
Fetal gastrointestinal anomalies are rather common: in newborns, the general incidence of 
gastrointestinal anomalies is approximately 6:1000 (Heinonen et al. 1977). Intestinal 
obstruction has been one of the most common emergencies in the neonatal period 
accounting for approximately ¼ of admissions to neonatal surgery units (Lister 1978). 
Esophageal atresia has an incidence of approximately 1:3500 in liveborns (Depaepe et al. 
1993; Torfs et al. 1995; Sparey et al. 2000). The incidence of duodenal atresia is 
approximately 1:10000 in newborns (Fonkalsrud et al. 1969). Imperforate anus has an 
approximate incidence of 1:1500 - 5000 in liveborns (Christensen et al. 1990; Stoll et al. 
1997; Cho et al. 2001). The birth prevalence of omphalocele has been stable for a long 
time at approximately 1:5000 (Baird and MacDonald 1981; Lindham 1981; Rankin et al. 
1999; Stoll et al. 2001). The incidence of gastroschisis has been increasing world-wide 
for unknown reasons (Penman et al. 1998; Rankin et al. 1999; Curry et al. 2000; 
Mastroiacovo et al. 2006). The previous incidence of approximately 1:10000 in most 
western countries has raised to 4.4:10000 in some countries (Brantberg et al. 2004; Kilby 
2006). Especially the incidence of gastroschisis among mothers younger than 20 years 
has dramatically increased and is now 1:400 in Great Britain (Kilby 2006). Except for 
low maternal age, no clear risk factors or etiology for the increased incidence of 
gastroschisis have been found. Maternal use of vasoactive drugs has been discussed, and 
use of aspirin in early pregnancy has been shown to increase the risk (Werler et al. 2002). 
Recent studies have discussed the effect of nutrition and increased fat intake (Siega-Riz et 
al. 2006) and the combination of young mothers, smoking and malnutrition have been 
suggested as part of risk factors (Lam and Torfs 2006).  
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It is important to emphasize that the incidence of anomalies is higher in a fetal population 
than among newborns. From our results in the non-selected population, the fetal 
incidence of esophageal obstruction was 1:3500, of duodenal obstruction 1:3517, of 
imperforate anus 1:1800, of omphalocele 1:2000 and of gastroschisis 1:2290. Altogether, 
the incidence of these 5 diagnoses that are discussed in this thesis was approximately 
2:1000. This means that they contribute to a high number of fetuses, all with a potential 
need for postnatal surgery. 
 
The epidemiology of fetal anomalies is still far from elucidated. In most epidemiologic 
studies of the incidence of anomalies, only liveborns are considered; spontaneous 
abortions and intrauterine fetal deaths are usually not counted or data are missing. In 
addition, termination of pregnancies have not always been included in the numbers (Leck 
1993). There is also an intermingling of diagnoses because various diagnoses were not as 
well mapped in previous studies as they are today. For example, abdominal wall defects 
were previously considered as basically the same condition while we now discriminate 
between several conditions with different outcomes. Our knowledge about biotechnology 
is improving very fast and genes that were not detected some years ago are now not only 
known but also eligible for prenatal DNA-testing and thereby new diagnoses are 
discovered (Cooper et al. 2005; Rooks et al. 2005).  
 
The completeness and validation of the data is also an issue when we compare and 
discuss the epidemiology of anomalies. In Norway, we have a well-defined population 
and available data of anomalies from the Medical Birth Registry of Norway (MFRN), 
which was started 40 years ago. However, there is a limitation in that the MFRN did not 
include terminations of pregnancies and stillbirths in their registration of birth anomalies 
prior to 1999. In addition, sometimes only one amongst several anomalies in the same 
fetus/infant is registered and anomalies that are not obvious at birth are not always 
included in the registry. As an example, in our non-selected population, from 1987 to 
2000, we had 11 cases of duodenal obstruction registered prospectively in our database. 
For the same population during the same time period, the MFRN had only 5 cases 
registered in their database, an underreporting of fifty percent. Of our 11 cases, 10 were 
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liveborn and should definitely have been included in the national registry. Further studies 
about the validity of the official registry of birth defects in Norway ought to be initiated. 
Underreporting of information in large official registries is known (Källén and Knudsen 
1989; Salvesen et al. 1990; Hey et al. 1994) and the quality assurance of the Norwegian 
birth registry has been discussed previously (Egenaes and Bjerkedal 1982). As the use of 
local high quality-assessed registries increases, we need to address the quality of the 
official registries.  
 
Fetal examination 
Ultrasound has given us the possibility to get detailed information about the fetus and the 
intrauterine environment. Ian Donald from Scotland was the first to introduce diagnostic 
ultrasound to obstetrics and gynecology (Donald et al. 1958; Donald 1962). Bertil 
Sundén, University of Lund in Sweden was inspired by Ian Donald’s work and indeed the 
first commercially made ultrasound machine, Diasonograph, was sold to the University of 
Lund. Sundén’s thesis from 1964 represents a pioneer work of the use and value of 
ultrasound in obstetrics and gynecology (Sundén 1964). Stuart Campbell initiated his 
work in the mid 60’s, and in 1968 presented his seminal work in which both A- and B-
mode scans were used to measure the fetal biparietal diameter (BPD) (Campbell 1968), a 
classical principle still used today. In 1969, he presented a normal growth curve for BPD 
(Campbell 1969). Kratochwil, from Austria, reported on fetal heart pulsation already 
from 7 gestational weeks in 1967 (Kratochwil and Eisenhut 1967) and in 1972, Hugh 
Robinson confirmed that fetal heart movement could be reliably detected with pulsed 
ultrasound from 7 gestational weeks onwards (Robinson 1972). 
 
Sundén demonstrated already in 1964 that acrania can be diagnosed with ultrasound 
(Sundén 1964). In 1972, Campbell was the first to report termination of an anencephalic 
fetus following prenatal detection (Campbell et al. 1972) and in 1975, he presented a case 
with spina bifida diagnosed by ultrasound (Campbell et al. 1975). The use of ultrasound 
in obstetrics rapidly expanded as the development of the technique and equipment 
continued (Levi 1997).  
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At the General Hospital in Malmö, University of Lund, Sweden, ultrasound was first 
introduced for systematic use during pregnancy in 1973 - 1974 (Grennert et al. 1978). 
The primary intention was to detect twins and the examinations were performed at 
approximately 28 weeks’ gestation. Soon the examination was moved to approximately 
17 weeks and later a second routine examination at 32 gestational weeks was added. The 
first country to introduce a routine fetal examination to their whole pregnant population 
was Germany in 1980 (Mutterschafts-Richtlinien 1980).  
 
In Norway, a routine fetal examination at approximately 18 gestational weeks for all 
pregnant women was introduced in 1986. The introduction was preceded by a consensus 
conference concerning the use of ultrasound in 1986 (Backe and Buhaug 1986). The 
recommendations to introduce a routine fetal examination were based on the reported 
decrease in post-term pregnancies (Eik-Nes et al. 1984) and the need to organize the 
already extensive use of ultrasound (Eik-Nes 1986). During the years that followed, 
additional European countries introduced routine fetal examinations such as Iceland in 
1987 (Geirsson 1987) and Austria in 1988. The Royal College of Obstetricians and 
Gynecologists (RCOG) published a report in 1984 on the routine use of ultrasound in 
pregnancy (RCOG 1984). At that time, among the concerns raised was the concern about 
the biological safety of ultrasound. The general conclusions were that the evidence that 
ultrasound may produce biological damage was not well founded and that benefits were 
likely from an ultrasound scan performed at approximately 16-18 gestational weeks. The 
report underscored the importance of adequate training. In the USA, the decision against 
a routine fetal examination was based on the RADIUS study (Ewigman et al. 1993) 
which did not show any improvement of perinatal outcome of those who underwent a 
routine fetal examination. However, the low detection rate of anomalies in the RADIUS 
study indicated that the potential of the examination was not fully exhausted, probably 
due to suboptimal basic skills of the ultrasound operators (Romero 1993; Eik-Nes et al. 
2000). Nowadays, most countries in Europe offer routine fetal ultrasound examinations, 
including evaluation of the anatomy, during pregnancy (SBU-rapport nr. 139, 1998). In 
Norway, a second consensus conference concerning the use of ultrasound in pregnancy 
was held in 1995 (Konsensuskonferanse 1995). One major reason for the conference was 
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the concern that fetuses with non-lethal anomalies would be terminated since the 
improving technology was making it possible to detect minor anomalies. The conference 
panel emphasized the importance of informed consent of the women, but decided to 
continue to offer a routine fetal examination. In Norway, midwives with special 
education in ultrasound usually perform these routine fetal examinations at approximately 
18 weeks’ gestation. Additional ultrasound examinations are made only on clinical 
indication. 
 
The purpose of the routine fetal examination was primarily to assess the gestational age 
in a better way than by the last menstrual period and to detect multiple pregnancies. 
Several studies have shown that the routine use of ultrasound for assessing the gestational 
age has decreased the number of post-term pregnancies (Eik-Nes et al. 1984; 
Waldenström et al. 1988; Geerts et al. 1996; Eik-Nes et al. 2000; Neilson 2000). 
According to the Cochrane database, the reduction was almost 40% (Neilson 2000). 
Another benefit of the dating by ultrasound was that the rate of SGA fetuses was reduced 
(Goldenberg et al. 1989; Waldenström et al. 1992) and it was possible to identify the 
fetuses with intrauterine growth retardation later in pregnancy with higher accuracy than 
previously. An additional purpose of the routine ultrasound examination was to determine 
the location of the placenta. 
 
Another purpose of the routine fetal examination was to perform an anatomical 
evaluation of the fetus. The benefit of the routine ultrasound examination in detecting 
fetal anomalies has been questioned. Some authors have emphasized the benefit of 
altering the obstetric management regarding timing and place of delivery (Luck 1992) 
while others have criticized it, claiming that no improvement of the perinatal outcome of 
fetuses who underwent a prenatal ultrasound examination has been proven (Ewigman et 
al. 1993). Indeed, the reduction in perinatal mortality after the introduction of routine 
fetal examination has been suggested to be an effect of increased rate of termination of 
pregnancies (Saari-Kemppainen et al. 1990; Zimmer et al. 1997; Liu et al. 2002). It has 
also been shown that a routine fetal examination with a high detection of fetal anomalies 
 28 
is cost-effective in relation to perinatal mortality (Leivo et al. 1996; Vintzileos et al. 
2000).  
 
The ability to detect fetal anomalies varies greatly (14% - 95%) in different studies 
(Campbell et al. 1983; Campbell and Pearce 1983; Lys et al. 1989; Chitty et al. 1991; 
Luck 1992; Ewigman et al. 1993; Saari-Kemppainen et al. 1994; Carrera et al. 1995; 
Chitty 1995; Stoll et al. 1995; Zimmer et al. 1997; Boyd et al. 1998; Grandjean et al. 
1998; Stefos et al. 1999; Levi 2002; Garne et al. 2005; Nikkilä et al. 2006; Saltvedt et al. 
2006). These differences reflect the experience of operators (Ewigman et al. 1993; Crane 
et al. 1994; Saari-Kemppainen et al. 1994; Chitty 1995), the selection of the examined 
population, the number of examinations and gestational age when the examinations were 
performed. The detection rate is also dependent on the classification of anomalies and the 
quality of the postnatal/postabortem examinations. In addition, the length of follow-up is 
important for the determination of the accuracy of the prenatal diagnosis (Levi 2002).  
 
In a review of 36 studies from 1978 - 1997, with a computed standardized sensitivity at 
2% prevalence, the sensitivity for prenatal detection of fetal anomalies varied from 8 - 
89.8% (Levi 2002). In the same review, which included 925 675 fetuses, the total 
sensitivity for detected anomalies was 40.3%. The studies are difficult to compare due to 
a large number of factors, but another review of routine fetal examinations concluded 
with 41.3% detection of fetal abnormalities before 24 weeks’ gestation (Bricker et al. 
2000). The importance of a second opinion and not relying on one single examination has 
been emphasized in order to increase the prenatal detection rate and avoid false positive 
diagnoses (Walkinshaw et al. 1992).  
 
In Scandinavia, the detection rate of fetal anomalies in non-selected populations at the 
routine fetal examination varied between 22 - 28% in 3 Swedish studies (Eurenius et al. 
1999; Nikkilä et al. 2006; Saltvedt et al. 2006) and was 39% in a Norwegian study 
(Nakling and Backe 2005).  
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The use of ultrasound at 11+0 - 13+6 gestational weeks has become more common and 
the detection rate of fetal anomalies in non-selected populations at the 11+0 - 13+6 week 
scan has been presented as 17 - 18% (Taipale et al. 2004; McAuliffe et al. 2005). The 
detection rate of fetal anomalies may be further improved when both an early scan and a 
routine examination in the second trimester are performed (Achiron and Tadmor 1991; 
Carvalho et al. 2002; Chen et al. 2004; Taipale et al. 2004).  
 
Many authors have described an increased detection rate of anomalies over time (Carrera 
et al. 1995; Levi et al. 1995; Stoll et al. 1995; Zimmer et al. 1997; Taipale et al. 2003) 
indicating a learning curve of the examiners. In our non-selected population, the detection 
rate for CHD’s increased from 18 to 57% between the periods 1986 - 1988 to 1991 – 
2001. The experience of the operator had a significant impact on the detection rate of 
CHD’s (Tegnander and Eik-Nes 2006). As a comparison, in a recent study with similar 
settings of population and examiners, the detection rate of major CHD’s was 13% 
(Westin et al. 2006). The increased detection rate in the study by Tegnander (Tegnander 
et al. 2006) was achieved after focus was placed on the fetal heart examination.  
 
Focusing on the detection of fetal anomalies in general may most likely increase the 
detection rate. However, the basic level of skills of the examiners must be satisfactory. 
ISUOG (ISUOG Educational committee 1996) and EFSUMB (Valentin et al. 2003) have 
proposed minimum training requirements for the practice of ultrasound in Europe and 
internationally. At the National Center for Fetal Medicine (NCFM) in Trondheim a 
postgraduate educational program in obstetric ultrasound for nurses/midwives was 
suggested in 1990 and was formally established in 1997. This educational program is run 
under the Norwegian University of Science and Technology. At present, it is the only 
program of its kind in Scandinavia. This one-year, part-time study combines theoretical 
education with clinical practice. The education of physicians and sonographers/midwives 
who are performing the fetal ultrasound examination is a prerequisite if fetal 
examinations are to be of benefit. In Scandinavia, recent studies from Sweden (Nikkilä et 
al. 2006; Saltvedt et al. 2006) show depressing results concerning detection rates of 
anomalies. One might discuss whether this reflects the lack of skill of the operators and 
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whether a formal education should be initiated. It is worth emphasizing that a few highly 
skilled specialists in fetal medicine make no difference for the population unless all “first-
line” examiners have the sufficient basic skills and knowledge to recognize the fetuses 
with abnormal findings and refer them for further evaluation. The quality of the fetal 
examinations will vary, but unless governments and professional societies give priority to 
the education of the operators, the level of quality might further decrease. As long as the 
basic education is insufficient, it will be impossible to meet the expectations of parents 
and society.  
 
It takes time to prove the advantages of new technology, especially when most single 
diagnoses have a very low incidence. In addition, it has often been the serious cases with 
a high mortality that have been detected prenatally. Despite this, improved outcomes for 
infants with a prenatal diagnosis of various anomalies have been demonstrated (Miro and 
Bard 1988; Romero et al. 1988; Bonnet et al. 1999; Tworetzky et al. 2001; Vilela et al. 
2001; Franklin et al. 2002; Bittencourt et al. 2004). Several studies emphasize the 
importance of rapid diagnosis and/or surgery after birth for improved outcome of certain 
anomalies (Cavanagh and Welty 1965; Lister 1978; Touloukian and Hobbins 1980; 
Lindley et al. 2006). The impact of prenatal diagnosis in Brazil has been discussed in 
studies of gastroschisis and duodenal obstruction, respectively (Vilela et al. 2001; 
Bittencourt et al. 2004). A study in Paris showed improved outcome for infants with 
anomalies that have been delivered at appropriate hospitals with specialized facilities (De 
Vigan et al. 1997). In Norway, with long distances to specialized neonatal care, a prenatal 
diagnosis might be significant for the outcome.  
 
Prenatal diagnosis of conditions that need postnatal surgery has been shown to reduce 
parental anxiety (Kemp et al. 1998) and the authors concluded:  
Fetal medicine centers have given pediatric surgeons the opportunity to 
change neonatal surgery from a predominantly unplanned emergency 
service, with all that implies in terms of anxiety and stress, to one that is 
almost semielective and planned, with a consequent reduction in the 
parental anxiety over what is still a major life event (Kemp et al. 1998).  
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The ultrasound examination during pregnancy has also been recognized as an opportunity 
for the parents to relate to their unborn child for the first time. The routine fetal 
ultrasound examination is important in this psychological “bonding” function (Sioda and 
Rybakowski 1984; Villeneuve et al. 1988; Sedgmen et al. 2006). The bonding (maternal-
fetal; paternal-fetal) has been discussed as having both psychological and moral 
significance (Fletcher and Evans 1983). It has been suggested that three-dimensional 
ultrasound has an even more positive influence on the maternal-fetal bonding (Ji et al. 
2005), but a later study has not confirmed these findings (Sedgmen et al. 2006). The 
verbal information during the ultrasound examination is important for the positive 
experience (Villeneuve et al. 1988) and verbal feed-back has been shown to reduce 
pregnancy anxiety and lead to fewer obstetric complications in primiparous mothers 
(Field et al. 1985). Further studies are needed to show if the impact of bonding might 
lead to a positive impact on the well-being of the fetus through a change in the mothers’ 
health behavior (Campbell 2006).    
 
Prenatal detection of gastroschisis and omphalocele  
It may be possible to detect abdominal wall defects prenatally in 100% of the cases. 
However, there has often been an intermingling of the various diagnoses of the 
abdominal wall (Walkinshaw et al. 1992). In two large European studies, the prenatal 
detection rate was 77% and 75% respectively for omphalocele, and 89% and 83% 
respectively for gastroschisis (Barisic et al. 2001; Garne et al. 2005). In our studies, the 
prenatal detection rate in the non-selected population was 100% for gastroschisis 
(Brantberg et al. 2004) and 95% for omphalocele (Brantberg et al. 2005). It is possible to 
diagnose gastroschisis already in the first trimester; the diagnosis has a high accuracy 
already then. Omphalocele is also possible to diagnose early (Brown et al. 1989; Blaas et 
al. 1995; van Zalen-Sprock et al. 1997; Blaas and Eik-Nes 1999). Epigastric defects are 
detectable before 12 weeks of gestation (Brown et al. 1989; Blaas and Eik-Nes 1999) and 
central defects may also be detectable at that early stage (Blaas et al. 1995; Blaas and 
Eik-Nes 1999). However, caution should be taken prior to the completion of the 
physiological herniation (Schmidt et al. 1987; Blaas et al. 1995; van Zalen-Sprock et al. 
1997; Blaas and Eik-Nes 1999). One should also be aware that a transient umbilical 
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hernia might mimic an omphalocele. One study reported several cases of isolated 
omphalocele diagnosed at 12 - 16 weeks which disappeared totally during pregnancy 
(Blazer et al. 2004).  
 
 
Prenatal detection of esophageal obstruction  
A prenatal diagnosis of gastrointestinal obstructions is not always possible. The more 
proximal the obstruction is situated, the more clinical symptoms it will give due to 
polyhydramnios. On the other hand, approximately 80 - 90% of cases with esophageal 
atresia have a tracheo-esophageal fistula (TEF) (Louhimo and Lindahl 1983) allowing the 
fluid proximal to the obstruction to be drained through the fistula and thereby giving 
fewer symptoms. A small or not visible stomach should always alert the examiner for a 
possible esophageal obstruction and additional polyhydramnios should increase the 
suspicion. The positive predictive value of a small or empty stomach and polyhydramnios 
is, however, low due to several other possible conditions (Stringer et al. 1995).  
 
The blindly ending proximal part of the esophagus, usually called the proximal or upper 
esophageal pouch, was described prenatally already in 1983 (Eyheremendy and Pfister 
1983). Prenatal visualization of this proximal esophageal pouch has received increasing 
interest during the last decades due to a high specificity for esophageal atresia (Satoh et 
al. 1995; Vijayaraghavan 1996; Centini et al. 2003; Has and Gunay 2004; Has et al. 
2004) and the pouch should always be searched for in suspected cases. The level of the 
pouch has been suggested to be of prognostic value (Kalache et al. 2000; Shulman et al. 
2002). Prenatal MRI (Langer et al. 2001) and three-dimensional ultrasound (Yagel et al. 
2005) might improve the accuracy of the prenatal diagnosis of esophageal obstruction.  
 
Although prenatal diagnosis of esophageal atresia was described already in the early 80’s 
(Farrant 1980; Zemlyn 1981; Pretorius et al. 1983), the rate of prenatal detection has been 
reported to be low, ranging between 9 - 42% (Pretorius et al. 1987; Stringer et al. 1995; 
De Vigan et al. 1997; Sparey et al. 2000; Kalish et al. 2003) and the diagnosis is usually 
not made before the third trimester. The fetal esophagus is possible to visualize already in 
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the first trimester (Blaas et al. 1995) and the esophagus can be detected in approximately 
90% of normal fetuses in the second and third trimester (Avni et al. 1994; Malinger et al. 
2004). The prenatal detection rate was 43% in our non-selected population and 44% in 
the selected population.   
 
Prenatal detection of duodenal obstruction  
The accuracy of the diagnosis of duodenal obstruction is high. The diagnosis is based on 
the typical “double-bubble” sign that arises from the dilated stomach and distended upper 
part of the duodenum and has a high specificity for duodenal obstruction. It is, however, 
important to confirm a clear connection between the stomach and duodenum for 
maintaining a high accuracy of the diagnosis. Polyhydramnios is usually present and its 
clinical signs are the most common reason for referral, leading to a targeted ultrasound 
examination. The diagnosis of duodenal obstruction is rarely made early in pregnancy. 
This may be due to immaturity of the gastric emptying, which reflects immaturity of the 
autonomic function (Lawrence et al. 2000). Fetal gastric motility is sporadic and 
infrequent before 20 weeks of gestation. Both gastric motility and gastric emptying 
significantly increase at around 24 weeks (Sase et al. 1999; Sase et al. 2000). However, it 
is important to note that any dilatation of the duodenum in the second trimester might be 
abnormal (Levine et al. 1998) and serial scans may be valuable (Nelson et al. 1982). The 
prenatal detection rate of duodenal obstruction in our non-selected population was 82% 
(Brantberg et al. 2002). 
 
Prenatal detection of imperforate anus  
Imperforate anus is usually not diagnosed until after birth and the diagnosis can rarely be 
verified prenatally. Antenatal diagnosis of imperforate anus has been reported (Bean et 
al. 1978; Grant et al. 1990; Guzman et al. 1995) sometimes as early as 12 weeks’ 
gestation (Lam et al. 2002; Taipale et al. 2005). Dilatation of the distal colon and/or 
rectum is the most common finding in prenatal detection of imperforate anus (Bean et al. 
1978; Harris et al. 1987; Hearn-Stebbins et al. 1991; Bronshtein and Zimmer 1996; 
Taipale et al. 2005). Abdominopelvic masses (Miller et al. 1990) or intraluminal 
calcifications may also raise suspicion of imperforate anus (Shalev et al. 1983; Grant et 
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al. 1990; Mandell et al. 1992). The appearance of fetal bowel changes with maturation 
(Zilianti and Fernandez 1983; Nyberg et al. 1987; Parulekar 1991) and dilatation of the 
bowel may also be a transient finding in normal fetuses (Bronshtein and Zimmer 1996) 
emphasizing the risk of over diagnosing, which may cause unnecessary parental anxiety. 
The prenatal detection rate in our study was 15.9% in the selected population and 11.1% 
in the non-selected population (Brantberg et al. 2006). 
 
Safety of ultrasound 
The possible side effects of ultrasound in obstetrics have been widely discussed due to 
the extensive use of the technique, also in normal pregnancies. Few other medical 
techniques have been investigated as thoroughly as ultrasound. So far, based on evidence 
currently available, performing routine ultrasound examination in pregnancy is not 
contraindicated (Salvesen 2002; Abramowicz et al. 2003). The international ultrasound 
societies have updated comments and statements concerning safety available on the 
internet: (ISUOG) www.isuog.org, (WFUMB) www.wfumb.org and (EFSUMB) 
www.efsumb.org. It is important to emphasize that every ultrasound operator is 
responsible for the safety; this implies the necessity of proper education. It is also worth 
emphasizing that all fetal examinations should have a clinical indication. The routine use 
of ultrasound at 18 weeks is considered a clinical indication. 
 
Ethics 
Diagnosis of diseases and anomalies in fetuses gives the possibility for treatment, focused 
surveillance and optimized postnatal care. However, some conditions represent a severe 
anomaly or disease and the parents may opt for a termination of the pregnancy. This 
option has been the reason for the ethical debates parallel with the development of 
ultrasound. In Norway, the concerns have primarily been related to the assumed risk of 
false positive diagnosis of anomalies leading to termination of pregnancies with normal 
fetuses. Later the question of whether or not the selective abortion of fetuses with certain 
characteristics is “ethical” was, and still is, heavily debated. There is no true, easy or 
overruling answer to these questions (Ethics Committee of the Swedish Medical Society 
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1993; Solberg 2003). It has been argued that human rights and dignity may be threatened 
if humans are not all accorded the same value. The Council of Europe has published a 
treaty with clear statements concerning preservation of human dignity, rights and 
freedom through a series of principles and prohibitions against the misuse of biological 
and medical advances (European Council 1997).  
 
The pregnant woman should give her informed consent prior to the examination. She is in 
a vulnerable condition and every ultrasound operator has to be educated and concerned 
about the way information is given. When a suspicion of an adverse development in an 
expected child is revealed to the parents, strong psychological reactions may be 
generated. When an anomaly or an adverse development is detected, a “perinatal team” 
comprised of various health professionals should be formed. The information to parents 
depends on the condition and gestational age of the fetus and the possibility for treatment. 
Our general experience is that thorough, repeated information with the possibility to ask 
questions, along with readily accessible health personnel, are of utmost importance in the 
acute phase. The ethical aspect must consider the autonomy of the pregnant woman, 
especially when it comes to decisions concerning possible termination of a pregnancy 
(Chervenak and McCullough 1991). The long-term psychological stress response 
associated with termination of pregnancy for fetal anomalies does not differ from the 
stress response seen in women who experience a perinatal loss (Salvesen et al. 1997).  
 
Centralization 
Most diagnoses of the fetus are such rare conditions that, under normal circumstances, a 
physician will only see a few in a lifetime. The field of fetal medicine is still under 
development and every single diagnosis is rare. Many fetal conditions are so rare that 
populations of several hundred thousands are needed to be able to draw any conclusions 
about the consequences that management has for the outcome. It is important that we use 
all possible knowledge that can be gleaned from rare cases. It is our responsibility to 
maintain and improve the knowledge of rare conditions. To improve our knowledge and 
thereby our management, it is important to collect the data from many cases which 
individually are rare. To be able to derive all possible data from every single rare case, it 
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is necessary to manage these cases at centralized units. For some diagnoses, the 
surveillance of the fetuses makes the difference between life and death for the infant. This 
surveillance is also the responsibility of a specialized, centralized unit. 
 
Several studies have shown an increased detection rate of fetal anomalies at tertiary 
centers compared to the detection rate by examiners at other institutions (Crane et al. 
1994; Saari-Kemppainen et al. 1994; Ogunyemi and Buskye 2000; Wong et al. 2003). 
Most likely this is due to a generally higher level of experience and an academic 
environment with more thorough knowledge. 
 
However, to receive the benefit of centralization, good co-operation with peripheral units 
is needed. A center and the peripheral units alike must recognize and experience that the 
benefits are dependent on a reciprocal relationship. The ability to find abnormal findings 
peripherally and the peripheral units’ willingness to refer these cases is crucial for a 
center in its efforts to obtain more experience and knowledge. A center can provide 
second opinion for the peripheral units as well as help and planning of the management of 
the cases that are in need for special management, including invasive procedures. 
Knowledge and outcome improvement is a result of continuous education and feedback. 
 
In countries with small populations, like Norway, it is especially important to centralize 
the care of rare conditions to be able to improve the outcome for fetuses and infants with 
certain conditions. 
 
Fetal population versus neonatal population 
Traditionally, the outcome of infants with congenital anomalies has been based on 
available data from liveborns, mostly including individuals that have survived through 
pregnancy and the immediate postnatal period. These selected individuals have been 
incorporated in the medical and surgical follow-up evaluations. Thus, the evidence of 
improved outcome over time has usually been based on selected individuals.  
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The routine fetal examination has provided us with new information that shows major 
differences between the fetal population and the neonatal population regarding the 
incidence and the development of anomalies. During the last 20 years, with a nationwide 
offer of routine fetal examination to all pregnant women, an increasing number of 
anomalies are detected already in utero. Most anomalies detected prenatally are 
diagnosed at the routine fetal examination at approximately 18 weeks. An increasing 
number of women have an ultrasound examination earlier in pregnancy and, depending 
on when an ultrasound examination is performed, various anomalies are detected at 
various gestational ages. Approximately 10 - 15% of clinically recognized pregnancies 
miscarry but the total reproductive losses, from conception to live birth, are 
approximately 50 - 70% (Chard 1991; Rai and Regan 2006). Based on a mathematical 
hypothesis, estimates of early pregnancy loss may be as high as 78% (Roberts and Lowe 
1975). Women are well aware of the risk for spontaneous abortions early in pregnancy 
and most know that the longer the pregnancy continues, the lower the risk for 
spontaneous loss. Approximately 50% of early (before 12 weeks) spontaneous abortions 
are due to abnormal karyotype (Boué et al. 1975; Plachot 1989; Chard 1991; Stephenson 
et al. 2002).  
 
 
Figure 7 
Gestational age-related risk for the most 
common chromosome abnormalities. The lines 
represent the relative risk according to the risk 
at 10 weeks’ gestation.  
Redrawn from data in “The 11-13+6 weeks 
scan” by Kypros H. Nicolaides, Fetal Medicine 
Foundation (FMF), London 2004.  
 
 
 
The risk for a fetus to have an abnormal karyotype is higher early in gestation. A fetus 
with an abnormal karyotype has a high risk for intrauterine death and/or spontaneous 
abortion and the risk is higher the earlier in pregnancy. Of fetuses diagnosed at 10 weeks 
with triploidy almost all are dead at 25 weeks’ gestation. Of fetuses with trisomy 13 and 
18, approximately 80% die during pregnancy, and of fetuses with trisomy 21, 
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approximately 40% die during pregnancy (Figure 7). When a diagnosis of abnormal 
karyotype is made at 18 weeks’ gestation, the risk for death is lower than at 10 weeks’ 
gestation due to the large number of fetal losses that have already occurred. These 
numbers are of value in the evaluation of fetuses with abnormal karyotype. Many fetal 
anomalies are associated with abnormal karyotype and it is important to be aware of these 
numbers in this context. When a prenatal diagnosis is made, the population includes a 
high number of fetuses with abnormal karyotype and also a high number of fetuses with 
the whole spectrum of fetal anomalies, syndromes, sequences etc. The numbers vary 
depending on the time of diagnosis, but in general, an early prenatal diagnosis reflects a 
more severe anomaly that is also more often associated with abnormal karyotype and 
other associated anomalies and syndromes. The spectrum of the severity of a specific 
diagnosis is more extensive, the earlier in pregnancy the diagnosis is made.  
 
Intrauterine fetal death occurs for many of the fetuses with abnormal karyotype and 
associated anomalies. Some women choose to terminate their pregnancies when the fetus 
has a serious or lethal condition. Thus, for some conditions like omphalocele, with a 
strong association with lethal abnormal karyotypes the fetal incidence is approximately 
1:1000 at 11 - 14 weeks’ gestation (Snijders et al. 1995; Snijders et al. 1995) while the 
live birth incidence is 1:5000. Of the 90 fetuses with omphalocele in our study (Brantberg 
et al. 2005) only 21 (23%) survived and only 8 (9%) infants were alive and healthy. This 
reflects a profound contrast to data based on neonatal populations with survival rate of 
approximately 90% (Mayer et al. 1980; Grosfeld et al. 1981; Mabogunje and Mahour 
1984; Rankin et al. 1999). Similar results were found in a study of prenatally detected 
congenital heart defects (Tegnander et al. 2006). Obviously, it is important to be aware of 
the differences of fetal and neonatal populations. This difference may apply to most fetal 
anomalies.  
 
A woman wants to know about the prognosis for her fetus at the time of diagnosis. To 
counsel and inform about the outcome based on neonatal populations is incorrect and 
may also mislead the woman who is trying to make a decision concerning her pregnancy. 
For a couple in a vulnerable situation, it must be of highest priority to provide as accurate 
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information as possible. It is also essential in maintaining the couple’s confidence in 
health personnel. Our main aim is to provide the best possible chances for fetuses with 
anomalies and diseases. On the other hand, we are obliged to keep in mind that some 
conditions are incurable and parents should be informed about that. 
 
Selected versus non-selected populations 
At a routine fetal examination offered to all pregnant women in a non-selected 
population, the whole spectrum of anomalies is present. However, the various anomalies 
appear rarely and the examiners need to be focused at every examination. The sensitivity 
for detection of anomalies is dependent on the prevalence in the examined population. 
Non-selected populations comprise both a low-risk and a high-risk population. A non-
selected population is not the equivalent of a low-risk population and it is incorrect to use 
the definitions interchangeably. However, a confusion of these definitions is commonly 
seen. A bias of the selection is also commonly seen due to inclusion of referred cases.  
 
Figure 8 
The non-selected population of Trondheim including 9 municipalities.  
 
              
 
The non-selected population in our studies came from a geographically well-defined area 
including the city of Trondheim and eight surrounding municipalities (Figure 8). Within 
this non-selected population, approximately 97% of the pregnant women who lived there 
had a routine fetal examination at the NCFM and were later delivered at the Trondheim 
University Hospital. The area is served only by Trondheim University Hospital for all 
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health care services including the Neonatal Intensive Care Unit, Pediatrics and Pediatric 
Surgery. Consequently, this is a true non-selected population.     
 
In non-selected populations, the prevalence of anomalies is relatively low. The detection 
rate of fetal anomalies is dependent on the operator’s ability to identify the fetuses that 
may need further evaluation. The challenge for them is to be focused at every 
examination. Operators examining non-selected populations are “specialists” in the 
normal appearance of the fetal anatomy and must trigger if something appears abnormal. 
The education of sonographers/midwives/physicians performing the routine fetal 
examination is extremely important in this regard. Appropriate education and sufficient 
experience of operators examining non-selected populations might increase the overall 
detection rate.  
 
In high-risk populations, fetuses are usually examined thoroughly, sometimes several 
times. The operators are skilled and use high quality equipment and the detection rate is 
high. For example, in non-selected or low risk populations examined by the routine staff 
at 18 - 22 weeks gestation 0 - 66% of congenital heart defects were detected (Crane et al. 
1994; Saari-Kemppainen et al. 1994; Rustico et al. 1995; Tegnander et al. 1995; Buskens 
et al. 1996; Todros et al. 1997; Tegnander et al. 2006; Westin et al. 2006) while 86% of 
major cardiac anomalies were detected already at examinations at 11 - 14 weeks in a 
high-risk population (Weiner et al. 2002).  
 
The increasing use of “tests in sequence” with early scans offered to a high number of 
women may affect the populations and an apparently non-selected population at 18 weeks 
may then become a low-risk population. This may be an important issue when results are 
compared. For example, if all pregnant women are offered 11+0 - 13+6 week scans for 
measuring the nuchal translucency, many of the fetuses with abnormal karyotype and 
some of the fetuses with congenital heart defects and other anomalies might already have 
been diagnosed prior to the routine examination. Consequently, fewer anomalies are 
expected within the population submitted to a routine fetal examination in the second 
trimester.  
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AIMS OF THE STUDIES 
 
The primary aim of the studies was to describe in a selected population: 
1. the outcome of fetuses with duodenal obstruction, gastroschisis and omphalocele 
from the time of prenatal diagnosis through the pregnancy and delivery and into 
the postnatal period (Papers I-III). 
2. the risk factors for poor outcome for fetuses with duodenal obstruction, 
gastroschisis and omphalocele, and to determine whether surveillance may be of 
benefit (Papers I-III). 
3. the different types of omphalocele and identify possible differences between these 
different types regarding associated anomalies and outcome (Paper III). 
4. the rate of prenatal diagnosis of esophageal obstruction and imperforate anus and 
elucidate possible strategies for improved diagnosis and their impact on the 
outcome (Papers IV-V). 
 
The additional (secondary) aim was to describe, in a non-selected population, the 
incidence, prenatal detection rate and accuracy of the diagnoses of gastroschisis, 
omphalocele, imperforate anus, duodenal and esophageal obstruction (Papers I-V).  
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MATERIALS AND METHODS 
 
Papers I, II and III were based on cases with a prenatal diagnosis of duodenal obstruction, 
gastroschisis and omphalocele, respectively. The cases were followed prospectively from 
the time of the diagnosis, through birth and into the postnatal period. Long-term outcome 
of fetuses was determined from postnatal charts after discharge from the hospital with a 
follow-up time of 0 - 16 years for Paper I (duodenal obstruction), 6 months - 15 years for 
Paper II (gastroschisis) and 1 - 17 years for Paper III (omphalocele). In Papers IV and V 
the study populations consist of all cases that had been through at least one prenatal 
ultrasound examination at the National Center for Fetal Medicine at any time during 
pregnancy and had been given the diagnosis of imperforate anus or esophageal 
obstruction either pre- or postnatally.  
 
In Norway, women have been offered one routine fetal examination at around 18 weeks’ 
gestation since 1986. Additional ultrasound examinations prior to or following the routine 
fetal examination have only been made on clinical indications. Around the country, 
midwives and physicians with varied training in obstetric ultrasound have performed the 
routine fetal examinations. In recent years, most midwives have passed the official 
education program introduced in 1997. At the National Center for Fetal Medicine, all 
midwives had at least basic training in obstetric ultrasound since 1986. When an anomaly 
was suspected physicians with special training in fetal medicine performed the 
examinations.  
 
Gestational age was expressed in completed weeks and days based on ultrasound 
measurements of the biparietal diameter at the routine fetal examination. Small for 
gestational age (SGA) was defined as a birth weight of less than mean  -2 SDs (Maršál et 
al. 1996).   
 
All 5 papers are based on a selected population consisting of referred cases, in addition to 
our own non-selected population. The non-selected population has also been investigated 
separately in order to establish the incidence and the prenatal detection rate as well as the 
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accuracy of the different diagnoses in such a population. The non-selected population 
comes from a geographically well-defined area consisting of the city of Trondheim and 
eight surrounding municipalities. Within the non-selected population, approximately 97% 
of the pregnant women who lived there had a routine fetal examination at the National 
Center for Fetal Medicine (NCFM) and were later delivered at the University Hospital of 
Trondheim. The NCFM has an extensive database in which data have been prospectively 
registered from the first ultrasound examination through pregnancy and birth. Since 1986, 
all newborns have been examined by a pediatrician (mostly one single person) and the 
immediate postnatal data are included in the database. Long-term postnatal follow-up 
data as well as results of the autopsies have gradually been incorporated in the database. 
In Paper I, the investigated time period of the non-selected population was 1987 - 2000 
and 38 683 infants were born during this period. The investigated time period in Paper II 
was 1988 - 2001 and included 38 924 births; Paper III, 1987 - 2002 included 43 957 
births and Papers IV and V 1987 - 2004 included 49 232 births.  
 
Statistical analysis of the difference in abnormal karyotypes between the different types 
of omphaloceles was performed by Fisher’s exact test (SPSS, version 11.0) (Paper III). 
Statistical analyses of the outcome for various esophageal obstructions were performed 
by Pearsons’s chi-square analysis (Paper V).  
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RESULTS AND COMMENTS 
 
Paper I  
Fetal duodenal obstructions: increased risk of prenatal sudden death 
Our data indicated that duodenal obstruction diagnosed prenatally represented a serious 
condition with a risk of prenatal bradycardia, asphyxia and death even when the 
karyotype was normal and no associated anomalies were present. 
 
Figure 9 
Ultrasound images of the “double-bubble” appearance typically seen in fetuses with duodenal obstruction 
(a,b). Duodenal atresia shown in a specimen from a fetus (c). 
 
a  b   c  
 
Results 
Twenty-nine cases with duodenal obstruction were followed from the time of prenatal 
diagnosis at mean 29+2 (range, 19+1 - 37+3) weeks. A routine fetal examination at 
approximately 18 gestational weeks had been performed in 26/29 cases but only three 
cases were detected at that examination. In all diagnosed cases, the “double-bubble” sign, 
caused by the dilated stomach and distended upper part of the duodenum, was observed at 
the ultrasound examination (Figure 9). The main reason for referral was polyhydramnios 
and its associated clinical conditions. Polyhydramnios was noted in 24/29 (83%) cases. 
Amniodrainage due to extensive polyhydramnios and a subjective feeling of pressure was 
performed in 12 cases; in 8 of these 12, the diagnosis was made after 32 weeks of 
gestation.  
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Associated anomalies were found in 18 fetuses (62%) (Table 2). Six (21%) had trisomy 
21. One pregnancy was terminated; the fetus had trisomy 21 and atrioventricular septal 
defect (AVSD) in addition to the duodenal obstruction. In 11 fetuses, the duodenal 
obstruction was an isolated finding. 
 
Table 2 
Type of associated anomalies in the 18 fetuses with duodenal obstruction and associated anomalies. 
 
 
 
Four fetuses (14%) died in utero at 31-35 gestational weeks. Two fetuses had no 
associated anomalies; one of these two had an episode of unexplained bradycardia 2 days 
before death. One had a hypoplastic gallbladder, diagnosed at the autopsy. One case had 
Goldenhar syndrome with facial anomalies and anomalies of columna, heart, lungs and 
hand. This fetus had long lasting episodes of bradycardia 1 week before the IUFD. All 
four died unexpectedly. In three cases, the mothers were staying in the hospital ward and 
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had normal CTG recordings within a day before death occurred. The fourth case 
presented because of reduced fetal movements. On the ultrasound examination, 
bradycardia and poor cardiac contractility were noted. The fetus showed vomiting-like 
movements. Asystolia occurred during the examination. The fetus with Goldenhar 
syndrome was small for gestational age (SGA), the other three had birth weights within 
normal range for gestational age (Maršál et al. 1996). The fetuses in all four cases of 
IUFD had duodenal atresia.  
 
Two infants with isolated duodenal obstruction developed severe neurological 
impairment; one had bradycardia during labor at 33 weeks and Cesarean section (CS) was 
performed. The infant had cerebral palsy, epilepsy, infantile spasms, neurological 
impairment and reduced motility of the left arm. The other fetus presented with reduced 
fetal movements at 35 weeks, the CTG recording was pathological and the fetus was 
immediately delivered by CS. Postnatal follow-up showed periventricular leukomalacia 
and the infant, who was also SGA, had epilepsy and cerebral palsy of diplegic type. 
 
Two additional infants suffered from impaired psychomotoric development; one with 
isolated duodenal obstruction was delivered normally at 38+5 weeks, the other had a 
normal delivery at 36+4 weeks. This infant had adducted thumbs bilaterally, but despite 
thorough tests and examinations with follow-up until the age of 7 years, no other 
associated anomalies or specific genetic syndrome has been diagnosed. 
 
In another fetus, a sustained period of bradycardia was observed during amniodrainage at 
32 weeks. Emergency CS was performed. Apgar scores were 9 and 10 after 1 and 5 
minutes. Arterial umbilical cord pH was 7.16 and base excess was -6.4 mmol/L. No 
obvious reason for the bradycardia was found during the amniodrainage or at the CS. The 
karyotype was normal and there were no associated anomalies. The postnatal 
development has been normal.   
 
Twenty-one of the 29 fetuses (72%) survived, but only six (21%) had normal karyotype, 
no associated anomalies and normal development during the postnatal period. 
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Comments 
It seems that fetal duodenal obstruction, also in isolated cases represented a more severe 
condition than previously believed. Of 11 fetuses with isolated duodenal obstruction, 5 
(45%) died or had substantially impaired neurological development. This means that the 
mortality and morbidity was high among the cases with duodenal obstruction where we 
would expect a good outcome following postnatal surgery. Furthermore, among cases 
with associated anomalies who experienced IUFD or neurological impairment, the 
anomaly was not of such nature that one would expect a serious outcome. All had normal 
karyotype, one had Goldenhar syndrome, one had a hypoplastic gallbladder and one had 
adducted thumbs.  
 
The esophagus is usually not dilated during pregnancy, but in fetuses with duodenal 
obstruction the esophagus can be seen substantially dilated (Figure 10a). This may 
induce a vagal reaction of the brainstem and a further vagal reaction of the heart, possibly 
leading to bradycardia and/or asystolia (Figure 10b). 
 
Figure 10 
Ultrasound image showing a distended esophagus and upper part of the stomach in a fetus with duodenal 
atresia (a). Schematic picture of the hypothesis of vagal overactivity (b). 
 
a        b   
 
This hypothesis is supported by findings in studies of nearly lost infants and siblings of 
sudden infant death syndrome (SIDS) victims, where gastro-esophageal reflux seems to have 
a central role in the occurrence of apparent life-threatening events (ALTE) (de Bethmann et 
al. 1993). Reflux may trigger vagal stimuli. The association of gastro-esophageal reflux and 
vagal overactivity in a study on infants who had suffered an ALTE was observed in 42% of 
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the ALTE group vs 18% of a control group (de Bethmann et al. 1993). Dilatation of the 
esophagus in dogs has been shown to cause frequent and reproducible cardiac response and it 
has been suggested that this condition in children under similar circumstances could cause 
ventricular defibrillation and death (Schey et al. 1981). Some of the children who die of 
SIDS may have had a vagovagal reaction initiated by esophageal dysmotility (Schey et al. 
1981). Esophageal spasm in association with bradycardia has been shown to be mediated by 
a vagovagal reflex mechanism (Fontan et al. 1984). The possibility of reversible cardiac 
asystolia due to paroxysmal vagal overactivity (VO) has been studied. In a review 
summarizing the role of VO in infants suffering from ALTE and SIDS siblings, it was 
confirmed that the most common rhythm disturbances in infants at risk for SIDS, were 
abrupt and brief episodes of bradycardia (Lucet et al. 2000). Gastro-esophageal reflux was 
assumed to be the main cause. In some of the fetuses with duodenal obstruction we have 
seen vomiting-like movements and also a very distended stomach and esophagus. We have 
also observed episodes of sudden bradycardia. It is possible that the same kind of 
paroxysmal vagal overactivity due to esophageal dysmotility and gastro-esophageal reflux as 
seen in children with SIDS and ALTE can occur in utero. This might be the cause of the 
unexpected fetal deaths in our study group. Bradycardia due to VO might also explain the 
cases of neurological sequelae in our study. 
 
Another possible mechanism that may affect the fetal heart rate is raised levels of fetal serum 
bile acids. Obstructions of the duodenum are usually situated close to the orifice of the bile 
duct and may affect the levels of fetal serum bile acids. The primary bile acid, taurocholate, 
can alter the rate and rhythm of cardiomyocyte contraction and cause abnormal Ca2+ 
dynamics in an in vitro system of neonatal rat cardiomyocytes (Williamson et al. 2001), a 
theory that also might explain the increased risk of intrauterine fetal death in obstetric 
cholestasis (Gorelik et al. 2002; Gorelik et al. 2004).  
 
The hypothesis that intrauterine fetal death in cases with duodenal and jejunal atresias, is due 
to bleeding from an umbilical cord ulcer has also been discussed. It has been speculated that 
in utero regurgitation of bile acid is responsible for the development of umbilical cord ulcer 
(Bendon et al. 1991; Ohyama et al. 2000; Anami et al. 2006). The concentration of bile acids 
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in amniotic fluid has been shown to be severely increased in cases with intestinal obstruction 
distal to the papilla of Vater (Deleze et al. 1977). In this context, it is important to remember 
that the presence of blood in the vomitus of newborns has long been considered an important 
diagnostic sign in cases with duodenal atresia (Cowell 1912). Fetal hemorrhage in cases with 
intestinal atresia, also without evident umbilical cord ulcer, has been reported and abnormal 
heart rate patterns with prolonged bradycardia and late decelerations have been noted 
(Shimizu et al. 2003). 
 
Our hypothesis of vagal overactivity may best explain the sudden fatalities, but more 
evidence is needed to establish a true etiology.  
 
Since the potential death in fetuses with duodenal obstruction seems to occur more or less 
instantly, surveillance is difficult. Continuous CTG monitoring after 30 weeks’ gestation in 
cases with intestinal atresia and polyhydramnios has been suggested (Shimizu et al. 2003), 
however, this may be impossible to accomplish. One may speculate whether it is beneficial 
to deliver fetuses with duodenal obstructions at approximately 32 weeks’ gestation to lower 
the risk of IUFD and the possible risk of asphyxia. Extensive amniodrainage may prevent the 
possibility of distension of the upper gastrointestinal tract in cases with polyhydramnios. 
Treatment with atropine or atropine-like drugs has been discussed and tried in infants (Schey 
et al. 1981; de Bethmann et al. 1993) and intrauterine treatment with such drugs might be a 
possibility in the future. Further studies are needed to find out more about the etiology. Until 
more knowledge is obtained, evaluation of the distension of the esophagus and delivery at 32 
- 34 weeks may rescue most of these fetuses.  
 
Paper II  
Surveillance and outcome of fetuses with gastroschisis 
Pregnancies with fetal gastroschisis should be considered high-risk pregnancies as 22% 
had pathological CTG, indicating fetal distress, leading to emergency CS before the onset 
of labor. Surveillance with CTG in the third trimester may improve the outcome through 
reducing the risk for IUFD. 
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Figure 11 
Ultrasound image of a fetus with gastroschisis (a). A newborn girl with gastroschisis (b). 
 
a  b  
 
Results and comments 
Gastroschisis is an abdominal wall defect, typically located on the right side of a 
normally inserted umbilical cord and with bowel protruding through the defect (Figure 
11). Sixty-four fetuses with a prenatal diagnosis of gastroschisis were followed from the 
time of a prenatal diagnosis. The diagnosis was usually made at the routine fetal 
examination. All fetuses had normal karyotype. Four (6.3%) had associated anomalies; 
two were cardiac anomalies (one VSD and one tetralogy of Fallot) and two had 
arthrogryposis of the amyoplasia type with extensive muscular atrophy.  
 
The low rate of 6.3% (4/64) of associated anomalies (except intestinal anomalies), was in 
agreement with other studies (Kirk and Wah 1983; Crawford et al. 1992; Burge and Ade-
Ajayi 1997; Rankin et al. 1999). The association of gastroschisis and arthrogryposis of 
the amyoplasia type has been previously described with a frequency of 3 - 5% (Hall et al. 
1983; Reid et al. 1986). A recent study has shown an increased incidence of cardiac 
anomalies in fetuses with gastroschisis and suggest cardiac evaluation of these cases 
(Kunz et al. 2005).  
 
Thirteen infants (22%) were SGA (Maršál et al. 1996) and the mean weight deviation at birth 
was -9%. The estimated and true weight deviation was in agreement in 59% of the cases. The 
ultrasound estimate of the day of delivery was postponed compared to the LMP estimate in 
75% of the cases at the routine fetal examination.  
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Infants with gastroschisis are known to be smaller than normal infants (Crawford et al. 
1992; Fries et al. 1993; Adair et al. 1996; Anteby et al. 1999; Barisic et al. 2001). The 
mechanism of becoming SGA in fetuses with gastroschisis has been suggested to be due 
to transmural loss of substances, particularly proteins. This may cause a nutritional drain 
from the fetus (Fries et al. 1993). The findings of lower serum protein concentrations and 
higher amniotic fluid total protein and alfa-feto protein levels in the fetuses with 
gastroschisis (Carroll et al. 2001) support this theory. It has also been proposed that the 
loss of proteins may cause hypovolemia and cardiovascular compromise (Dixon et al. 
2000), which may contribute to the risk of fetal distress and IUFD. Traditional methods 
for estimation of fetal weight may be used in fetuses with gastroschisis since the 
correlation of the estimated weight and true weight was relatively good. The same results 
have been shown previously (Fries et al. 1993) and it has been suggested that it is the 
liver (which is normally intra-abdominal in cases with gastroschisis) that contributes most 
to the size in the abdominal measurements (Fries et al. 1993). The fact that 75% of the 
women had their estimated day of delivery postponed at the routine fetal examination 
suggests that some of the fetuses with gastroschisis are smaller already in the second 
trimester, since postponement of the term is usually seen in only 60% of fetuses in a non-
selected population (Tunon et al. 1996). This may have consequences for the extensive 
discussions regarding when to deliver fetuses with gastroschisis. In previous studies on 
the timing of delivery for fetuses with gastroschisis the method for determining 
gestational age has rarely been described (Huang et al. 2002; Moir et al. 2004; Ergün et 
al. 2005; Logghe et al. 2005). Before drawing conclusions about the best time of 
delivery, it is necessary to know the methods for collecting the data that are to be used as 
evidence. Mean gestational age at delivery in our study was 36+1 weeks (Table 3), based 
on ultrasound measurements of the BPD during the routine fetal examination at 
approximately 18 weeks. Our policy during the period of the study was to deliver fetuses 
with gastroschisis by CS at 37 - 39 weeks.  
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Table 3 
Indication, gestational age and mode of delivery in cases with gastroschisis (n = 60). 
   
 
Usually, gastroschisis is an abdominal wall defect with bowel protruding through a small 
hole on the right side of the umbilical cord insertion. However, also left-sided 
gastroschisis has been reported (Ashburn et al. 2002; Yoshioka et al. 2004). Other 
atypical cases with gastroschisis also exist (Pinzon and Barr 1995). It is important to be 
aware of these rare cases because they usually have a poor outcome. In our study group, 
we had one such case with a large defect reaching from the right side of the umbilicus to 
the left costal margin and with the whole liver exteriorized. We have called this an 
“epigastric gastroschisis” due to the location of the defect.  
 
Also in typically right-sided gastroschisis, organs other than bowel may be present extra-
abdominally (Hutchin 1965; Moretti et al. 1990; Novotny et al. 1993). In our study, this 
was particularly common among girls whose gonads and urinary bladder were more often 
seen extra-abdominally than among the boys (Table 4). The involvement of gonads may 
affect future fertility (Koivusalo 2002) and caution during surgery is necessary. The 
stomach or part of the stomach was commonly noted extra-abdominally and this may 
affect the immediate postnatal management due to the increased risk of aspiration 
(Tannouri et al. 1998). It has also been suggested in a case report (Nazir et al. 2005) that 
a persistent fetal gastric distension may be associated with decreased fetal movements 
and non-reactive CTG. 
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Table 4  
Viscera and organs (or part of) exteriorized before surgery in cases with gastroschisis.    
 
 
 
Intra-abdominal dilatation of the fetal bowel was noted in five cases in our study, and all 
had obstruction of the bowel (Figure 12). In the years that followed, 30 additional cases 
were studied; the association of intra-abdominal dilatation and obstruction of the bowel 
was further confirmed (Brantberg et al. 2006). Similar results were recently published in 
another study (Nick et al. 2006). In our study, obstruction of the bowel was not 
associated with poor outcome. This confirms the findings reported in previous studies 
(Driver et al. 2000; Fleet and de la Hunt 2000; Snyder et al. 2001). However, it is worth 
emphasizing that cases with atresia and the presence of massive peel at birth may benefit 
from delayed primary anastomosis (Fleet and de la Hunt 2000). 
 
Figure 12 
Normal appearance of bowel in a newborn with gastroschisis (a). Ultrasound image showing intra-
abdominal dilatation of the bowel in a fetus with gastroschisis and intestinal atresia (b). Appearance of the 
bowel in a newborn with gastroschisis complicated by atresias and presence of “peel” (c).  
 
a  b  c  
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In this context, it is important to note that intra-abdominal dilatation of the bowel might 
be associated with “closed gastroschisis” (Barsoom et al. 2000; Davenport et al. 2001) 
which means that the abdominal wall defect narrows and eventually closes (Figure 13a). 
In “closed gastroschisis”, the intra-abdominal dilatation is usually newly developed in the 
third trimester and increases over time. This complication is rare, but might be fatal since 
the whole bowel may be necrotic (Winter et al. 2005). Delivery with immediate dilation 
of the opening is needed on these rare occasions (Figure 13b).  
 
Figure 13 
A newborn at 29+3 weeks with closed gastroschisis (a) and surgical dilation of the defect (b) 
 
a      b  
 
 
In 13 of the 60 cases (22%), pathological CTG’s developed, leading to emergency CS 
prior to labor. The typical pathological findings of the CTG were reduced short-term 
variability and sometimes, additionally tachycardia. Several authors have addressed the 
increased risk of fetal distress (Adair et al. 1996; Burge and Ade-Ajayi 1997; Anteby et 
al. 1999) and the increased risk of IUFD (Crawford et al. 1992; Adair et al. 1996; Burge 
and Ade-Ajayi 1997). The rate of IUFD in fetuses with gastroschisis has been reported to 
be 10 - 15% (Calzolari et al. 1995; Adair et al. 1996; Burge and Ade-Ajayi 1997; Barisic 
et al. 2001). In our study, the rate of IUFD was 1.6%, one case; the pregnant woman in 
this particular case did not want to follow our normal surveillance program. The CTG 
surveillance of the other cases may have been the reason for the low rate of intrauterine 
deaths. The typical CTG pathology with reduced short-term variability in our study has 
also been reported in previous studies (Ingamells et al. 1995; Axt et al. 1999). A 
tendency to develop tachycardia has also been described previously (Salomon et al. 
2004). Antenatal surveillance has been suggested to decrease perinatal mortality in cases 
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with gastroschisis (Adair et al. 1996) and the introduction of regular CTG monitoring 
from 32 weeks’ gestation increased the detection of fetal distress (Burge and Ade-Ajayi 
1997). The increased ability to detect fetal distress, with subsequent obstetric 
intervention, led to a reduction of adverse neurological outcome from 21% to 6% (Burge 
and Ade-Ajayi 1997). Another study started CTG monitoring at median 30 weeks and, in 
this small study, 35.5% developed pathological CTG leading to emergency CS (Salomon 
et al. 2004). The prenatal surveillance may have been the reason for the low perinatal 
mortality of 3.2% (1/31) in this study. 
 
We have intensified our surveillance with CTG monitoring daily from 33 gestational 
weeks as a consequence of our study. This recently introduced type of surveillance 
program has also been adopted by other institutions around the world. Even though the 
underlying reasons for the increased risk of fetal distress have not been clarified, the 
importance of fetal monitoring has been discussed (Drewett et al. 2006). The mechanism 
for development of pathological CTG is not known. We suggest that hypovolemia due to 
protein loss may be a cause. This has previously been suggested (Carroll et al. 2001) to 
cause cardiovascular compromise and may play a bigger role than previously believed. It 
has long been known that infants with gastroschisis are in need of substantial volumes of 
fluid (Philippart et al. 1972) and it has been thought that the reason was fluid loss due to 
the exposed bowel and heat loss postnatally. It has not been possible to calculate the 
prenatal volume losses and there are no good methods to determine hypovolemia in 
fetuses. One study found raised levels of amniotic fluid ß-endorfin, a neuropeptide which 
may be associated with fetal distress associated with hypoxia and acidosis, in fetuses with 
gastroschisis with worse postnatal outcome (Mahieu-Caputo et al. 2002). The reasons for 
IUFD and fetal distress in fetuses with gastroschisis are most likely multifactorial. An 
autonomic vagal reaction due to bowel and/or stomach affection/pressure may also play a 
role. Until all underlying reasons are clarified, close CTG surveillance of fetuses with 
gastroschisis may improve the outcome through detection of fetal distress and thereby 
reduce the risk of IUFD. It has been argued that the CTG pathology is not associated with 
fetal distress because the infants with gastroschisis that have been delivered due to 
pathological CTG have had normal Apgar (Dixon et al. 2000). On the other hand, one 
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may argue that the lower rate of IUFD in the studies with CTG monitoring is obvious and 
our aim must be to deliver in due time before irreversible damage to the fetus has 
occurred.  
 
The impact of time and mode of delivery in fetuses with gastroschisis has been widely 
discussed (Lenke and Hatch 1986; Moretti et al. 1990; Sakala et al. 1993; Quirk et al. 
1996; Dunn et al. 1999; Moore et al. 1999; Ergün et al. 2005). Randomized controlled 
trials have not been possible to perform concerning mode of delivery and there is no clear 
evidence that advocates one specific mode of delivery. One small randomized controlled 
trial has been performed concerning the time of delivery (Logghe et al. 2005) in which 
elective preterm delivery at 36 weeks was compared to awaiting spontaneous delivery. 
No benefit from either policy was demonstrated, but it is worth mentioning that four 
fetuses in each group (in total 8/40 (20%)) were delivered before 36 weeks. Our policy of 
delivering fetuses with gastroschisis by CS at 36 weeks of gestation is based on several 
issues. First, the mean gestational age at delivery in our study was 36 + 1 weeks, even 
when we had the policy to deliver as late as possible; the cases who developed 
pathological CTG indicating risk for fetal distress were delivered at mean 36+4 weeks. In 
addition, also in studies advocating vaginal delivery, the rate of CS was 37% - 51% 
(Blakelock et al. 1997; Anteby et al. 1999). Minor additional issues are that, even if there 
is no statistical evidence, both sepsis and bowel damage in the infants may be lower after 
CS and that the surgery for the infants can be planned appropriately.        
 
Numbers including 63 cases from the Medical Birth Registry of Norway (MFRN) show a 
rate of 14.3% stillbirths and a 16.0% termination rate of pregnancies (TOP) of 
gastroschisis during a period of 4 years (Table 5). These numbers emphasize that also in 
Norway, the rate of intrauterine fetal death of gastroschisis is high. However, it was most 
surprising to find that the rate of termination of pregnancies with gastroschisis was so 
high. The incidence of gastroschisis is increasing and the longterm outcome for infants 
that have survived the perinatal period is usually excellent. 
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Table 5 
Outcome of cases with gastroschisis in the selected population of Trondheim presented in the study 
compared to outcome of cases with gastroschisis during four years from the Medical Birth Registry of 
Norway (MFRN). 
 
 
 
We need to call attention to the fact that approximately 30% of the gastroschisis cases 
listed in the national registry either were terminated (16%) or suffered an IUFD (14.3%). 
Most likely, the knowledge about the prognosis among physicians managing these cases 
has not been updated, thus the high rate of terminations. The national figures also indicate 
that the antenatal surveillance ought to be improved and maybe centralized to avoid these 
IUFD’s that most likely are unnecessary. In Norway, pediatric surgery is centralized to 
two institutions, Rikshospitalet University Hospital in Oslo, and St Olavs Hospital, 
Trondheim University Hospital in Trondheim. Despite this, we know that some infants 
with gastroschisis receive surgery at their local hospital and will not benefit from surgery 
at appropriate places with highly specialized and experienced pediatric surgeons, a fact 
that most probably also affects the postnatal survival. 
 
Paper III  
Characteristics and outcome of 90 cases of fetal omphalocele 
This study of fetuses with omphalocele showed a poor outcome. Of those diagnosed 
prenatally, only 8/90 (9%) infants were alive and healthy, indicating that this is a serious 
diagnosis. Furthermore, our results indicated that central and epigastric omphaloceles 
might be different entities. 
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Figure 14 
Epigastric omphalocele.  
Ultrasound image (a). Newborn before surgery (b). Newborn after surgery (c). 
 
a   b  c  
 
Figure 15 
Central omphalocele.  
Ultrasound image (a). Newborn before surgery (b). Newborn after surgery (c).  
 
a    b      c  
 
Results and comments 
In omphaloceles, the bowel and/or liver protrude(s) into the umbilical cord. A membrane 
consisting of peritoneum and amnion encloses the eviscerated organs (Figures 14, 15). 
The study comprised 90 fetuses with a prenatal diagnosis of omphalocele. The cases were 
followed from the time of prenatal diagnosis at mean 18+4 (range, 10+2 - 39+1) weeks. 
Omphaloceles were subdivided into epigastric, central and hypogastric based on the 
location of the defect and the insertion of the umbilical cord. Central omphaloceles were 
found in 58 (64%) fetuses, 32 (36%) had epigastric omphaloceles and none had a 
hypogastric omphalocele. Periumbilical defects were classified as central, irrespective of 
size or content. Omphaloceles involving the epigastric abdominal wall but not reaching 
below the umbilicus were classified as epigastric.  
 
Different types of omphalocele have different risks for abnormal karyotype. The most 
commonly used characterization has been to differentiate between liver- and bowel-
containing omphalocele. Fetuses with only bowel in the sac have a higher rate of 
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abnormal karyotype than fetuses with liver protruding into the sac (Hughes et al. 1989; 
Nyberg et al. 1989; Benacerraf et al. 1990; Getachew et al. 1992; Nicolaides et al. 1992; 
De Veciana et al. 1994). In our study, abnormal karyotypes were found in 40/58 (69%) of 
the fetuses with central omphaloceles and in 4/32 (12.5%) of the fetuses with an 
epigastric defect. The difference in abnormal karyotype was even stronger according to 
this classification system when compared with two previous large fetal series (Nicolaides 
et al. 1992; Snijders et al. 1995). The central and epigastric omphaloceles may be 
different entities. The most frequent abnormal karyotype in our study was trisomy 18 
(Table 6).  
 
Table 6 
Abnormal karyotype in fetuses with central and epigastric omphalocele (n = 44). 
 
Normal karyotype in fetuses with a central omphalocele was present in 18/58 (31%) and 
16 of these 18 (89%) had associated anomalies. Of the fetuses with an epigastric 
omphalocele, 28/32 (87.5%) had normal karyotype and 20 of these 28 (71%) had 
associated anomalies. This underscores that when an omphalocele is diagnosed prenatally 
not only karyotyping, but also an extensive search for additional anomalies is indicated. 
Cardiac anomalies are the most frequently reported anomaly in association with 
omphaloceles with normal karyotype (Fogel et al. 1991; St-Vil et al. 1996; Heider et al. 
2004) emphasizing the need for fetal echocardiography when abnormal karyotype is ruled 
out (Table 7). 
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Table 7 
The most frequent structural anomalies in 36 cases of omphaloceles with normal karyotype. 
  
 
Omphaloceles may also be associated with syndromes such as Donnai-Barrow syndrome 
(Donnai and Barrow 1993) and acrocallosal or hydrolethalus syndrome (Christensen et 
al. 2000), both present in our study. These syndromes are both recessive inherited 
disorders implying the need for genetic counseling in future pregnancies. A genetic test 
of these syndromes might be available in the future.  
 
Beckwith-Wiedemann syndrome (Wiedemann 1964) is the most well-known syndrome in 
association with omphalocele. Genetic testing is available for some of these cases and 
testing for uniparental disomy in chromosome 11 may be possible (Feinberg 2000; Maher 
and Reik 2000; Weinstein and Goldstein 2002). Owing to the wide variation in 
expression of this syndrome, a test may not always be helpful at the moment. With recent 
identification of molecular subtypes in different phenotypic expression of Beckwith-
Wiedemann (Cooper et al. 2005), genetic testing may be most valuable in the future, both 
for accurate prognosis and for the postnatal surveillance. With ultrasound, the diagnosis 
of Beckwith-Wiedemann syndrome may be impossible early in pregnancy and fetuses 
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with Beckwith-Wiedemann syndrome have mistakenly been assumed, at ultrasound, to 
have an isolated omphalocele (Hughes et al. 1989; Boyd et al. 1998).   
 
Isolated omphalocele was present in only 11% of all fetuses with omphalocele. The 
overall survival was 23%, but only 9% survived without sequelae, underscoring the fact 
that a fetal omphalocele is a serious condition with a high level of associated anomalies 
and impairments (Figure 16). Abnormal karyotype or serious and/or multiple associated 
anomalies were consistently associated with poor outcome, with 97% mortality and 3% 
impairment. A thorough diagnosis makes it possible to locate this subgroup of fetuses 
with fatal/poor prognosis. The aim of pregnancy management must be to identify these 
and concentrate the surveillance on those whose prognosis is believed to be favorable. 
 
Figure 16 
Outcome of 90 fetuses with prenatally detected omphalocele.  
IUFD, intrauterine fetal death; TOP, termination of pregnancy.  
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Paper IV  
Imperforate anus: a relatively common anomaly rarely diagnosed prenatally 
Imperforate anus was often found in conjunction with other serious anomalies, leading to 
a significant morbidity and mortality. In this study, including both fetuses and newborns, 
additional anomalies were present in 85.5%. Most additional anomalies were diagnosed 
prenatally but imperforate anus was diagnosed or strongly suspected prenatally in only 
15.9% of the cases.  
 
Figure 17 
Imperforate anus in a newborn boy (a) and girl (b). Ultrasound image showing dilatation of the lower bowel 
and intraluminal calcifications in a fetus with imperforate anus at 18 weeks’ gestation (c). 
 
a        b       c  
 
Results and comments 
The study comprised 69 cases with imperforate anus. A prenatal diagnosis of associated 
anomalies and/or imperforate anus was made in 53 cases while in 16 there were no 
pathological prenatal findings. Imperforate anus was diagnosed prenatally in 11 (15.9%) 
fetuses at a median gestational of 18+4 (range, 15+6 - 35+6) weeks. All 11 had a 
dilatation of the rectum or lower part of the bowel and two also had intraluminal 
calcifications (Figure 17c).   
 
Isolated imperforate anus was found in 10/69 cases (14.5%) while additional anomalies 
including abnormal karyotype were present in 59/69 (85.5%) (Table 8). Most cases, 
51/59 (86.4%), had multiple anomalies. The most frequent additional anomalies were 
found in the urogenital tract and several of them were lethal. 
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Table 8 
The most common anomalies involved in 59 cases with imperforate anus and additional anomalies.  
Most (51/59) (86.4%) cases had several anomalies. TEF, tracheoesophageal fistula. 
  
 
The high rate of associated urogenital anomalies affecting renal function and leading to 
oligo-/anhydramnios may have affected the prenatal detection rate. On the other hand, the 
detection rate of 15.9% in our study was higher than in previous reports (Stoll et al. 1995; 
Stoll et al. 1996). The known association of imperforate anus and trisomy 21 (Black and 
Sherman 1989; Zlotogora et al. 1989; Torres et al. 1998) was confirmed and the rate of 
approximately 5% in our study was in line with former reports (Zlotogora et al. 1989; 
Endo et al. 1999). This significant knowledge, although it is well documented, is still not 
so well known. Imperforate anus is often part of the association of vertebral anomalies 
(V), anal atresia (A), tracheo-esophageal fistula with esophageal atresia (TE) and renal 
dysplasia (R) (VATER) or VATER plus cardiac (C) and (L) limb anomalies (VACTERL) 
association (Quan and Smith 1973), but other associations, syndromes and sequences 
have also been frequently reported to include anorectal anomalies (Hassink et al. 1996). 
Awareness of the kinds of various anomalies that may be associated with imperforate 
anus might improve the prenatal detection rate by a more intensified, targeted search for 
imperforate anus in cases with these anomalies. This suggestion was confirmed in a case 
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report of monoamniotic twins (Guzman et al. 1995) when the features of VACTERL 
alerted the examiner to search more specifically. It has also been suggested that 
additional MRI examination might add more conclusive information (Veyrac et al. 2004) 
in cases with a high suspicion of anorectal anomalies at ultrasound. 
 
Videotapes that show the anorectal area from examinations of fetuses without a prenatal 
suspicion of imperforate anus were available for 22 cases, and these tapes were re-
evaluated retrospectively. A strong suspicion of imperforate anus with dilatation of the 
rectum was apparent in one case on the tapes of examinations at both 10+0 and 13+0 
weeks’ gestation. In ten additional cases, signs of imperforate anus were detectable at 
examinations at mean 21+1 (range, 16+1 - 34+1) weeks. In 11 cases, examined at a mean 
of 22+2 (range, 14+6 - 34+3) weeks, no signs at all of imperforate anus were detected, 
even when the anorectal area was sufficiently demonstrated on the video evaluated 
retrospectively. 
 
The survival rate of infants with isolated imperforate anus and of infants with only one 
additional anomaly was high (94.4%), irrespective of whether or not a prenatal diagnosis 
was made, while the survival rate among fetuses/infants with multiple additional 
anomalies was only 13.7% (Figure 18).  
 
For the individuals that survive, issues such as fecal and urinary continence, sexuality and 
fertility are of importance. Females in particular have a high rate of genital anomalies that 
may affect future fertility (Fleming et al. 1986). Various types of imperforate anus are 
managed differently and have different surgical approaches and outcomes (Pena 1995). 
Even if reconstructive anorectal surgery is not urgently needed, immediate evaluation of 
infants with imperforate anus is necessary and decompressive surgery may be urgently 
required. This means that delivery at a center with neonatal intensive care and pediatric 
surgery facilities may be important. 
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Figure 18 
Outcome of 69 cases with imperforate anus.  
IUFD, intrauterine fetal death. 
  
  
Delays in the diagnosis of anorectal malformations postnatally are common and 
significantly increase serious early complications (Lindley et al. 2006). Not only 
thorough examination postnatally, but also increased prenatal diagnosis might improve 
the outcome for these infants. Prenatal diagnosis is not always possible. Nevertheless, 
awareness of the condition and the ability to recognize the most typical ultrasound 
findings in imperforate anus may improve the detection rate. A heightened awareness of 
the high rate of associated anomalies and the type of anomalies commonly seen together 
with imperforate anus may also be important for improving the prenatal detection rate. 
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Paper V  
Esophageal obstruction - prenatal detection rate and outcome 
The clinical signs of polyhydramnios were the most important factors for prenatal 
detection of esophageal obstruction. Consequently, the time of diagnosis was late and the 
detection rate was low (44%). The detection rate might be improved by an increased 
awareness of the possibility of esophageal obstruction, which would lead to targeted 
examinations. Ninety percent of the cases with isolated esophageal obstruction survived 
irrespective of whether or not the diagnosis was made prenatally. 
 
 
 
Figure 19 
Schematic picture and ultrasound image of 
esophageal atresia with TEF and visualization 
of the proximal esophageal pouch.  
Results 
The study comprised 48 cases with esophageal obstruction, 46 with esophageal atresia, 
one with esophageal stenosis and one with a functional obstruction as a consequence of a 
laryngo-tracheo-esophageal cleft type IV. 
  
A prenatal diagnosis of esophageal obstruction was made in 21/48 (44%) fetuses at 
median 32+0 (range, 17+6 - 36+6) weeks. Polyhydramnios was present in 20/21 (95%) of 
the prenatally detected cases and in all the fetal stomach was either small or not visible. 
Esophageal pouch was visualized prenatally in 9/21 (43%) of these cases (Figure 19). 
Only one false positive case was present in our study, while previous studies have 
presented a high rate of false positive cases (Sparey et al. 2000). This means that the 
diagnosis had a high accuracy despite that more than half of the prenatally detected cases 
had only indirect signs. Seventeen (81%) of the 21 cases with prenatally detected 
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esophageal obstruction were diagnosed after 28 weeks, and all but one had clinical 
symptoms of polyhydramnios.  
 
 Associated anomalies including abnormal karyotype were present in 38/48 (79%) of all 
cases with esophageal obstruction. Eleven of the 48 cases (23%) had abnormal karyotype. 
In addition, the only case with esophageal stenosis had Di George syndrome. The most 
frequent associated anomalies were cardiac followed by urogenital anomalies. Among the 
cases with normal karyotype, the most common anomalies were urogenital followed by 
imperforate anus. 
 
 Figure 20 
Outcome of 48 cases with esophageal obstruction. 
 
 
Ten women of all 48 (21%) chose to terminate their pregnancies due to lethal associated fetal 
anomalies. Two fetuses (4.2%) died in utero; one with multiple associated anomalies died at 
28+1 weeks, one fetus which was growth retarded had an isolated esophageal atresia with 
TEF and died at 22+1 weeks. Thirty-six fetuses, including all 21 with a prenatal diagnosis of 
esophageal obstruction, were alive until delivery. Mean birth weight was 2300g and mean 
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gestational age at delivery was 36+1 weeks. Thirteen infants (36%) were small for 
gestational age (Maršál et al. 1996). Of the 21 cases with a prenatal diagnosis of esophageal 
obstruction, 16/21 (76%) survived, compared to 10/29 (37%) of the cases without a prenatal 
diagnosis of esophageal obstruction (P = 0.14). When obvious lethal associated conditions 
were excluded, 16/16 (100%) of the cases with a prenatal diagnosis of esophageal 
obstruction survived and 10/14 (71%) of the cases without prenatal diagnosis of esophageal 
obstruction survived (P = 0.54). Of the 10 cases with isolated esophageal obstruction, 9/10 
(90%) survived compared to 17/38 (45%) of the cases with esophageal obstruction and 
associated anomalies (P = 0.20) (Figure 20). 
 
Comments: 
The clinical signs of polyhydramnios were the most important factors for prenatal detection 
of esophageal obstruction. Consequently, the time of diagnosis was late (median 32+0 
weeks) and the detection rate was low (44%). Surprisingly, the detection rate in the non-
selected population was the same (43%). Despite the possibilities of performing 3D-
ultrasound or MRI in suspected cases to improve the accuracy and detection rate, this was 
not done in any of the cases. The accuracy was, on the other hand, high and in contrast to 
previous studies (Sparey et al. 2000) we had only one false positive case. One may argue that 
with a higher suspicion the detection rate might have been higher. Recently, a new method 
was suggested for diagnosing esophageal atresia without fistula by measuring the distance 
between aorta and left atrium (Develay-Morice et al. 2006).  
 
In this study, associated anomalies were present in 79% of the fetuses, which is higher than 
in previous reports (Louhimo and Lindahl 1983; Rokitansky et al. 1994; Saing et al. 1998; 
Sparey et al. 2000; Yagyu et al. 2000; Kalish et al. 2003; Lopez et al. 2006). Also, the 23% 
rate of abnormal karyotype in the present study was higher than that reported in other studies 
(Louhimo and Lindahl 1983; Rokitansky et al. 1994; Sparey et al. 2000; Yagyu et al. 2000; 
Kalish et al. 2003). This may be explained by the relatively more prenatally diagnosed cases 
included in our series than have been included in previously published series. Most previous 
studies are based on neonatal populations (Louhimo and Lindahl 1983; Rokitansky et al. 
1994; Saing et al. 1998; Yagyu et al. 2000; Lopez et al. 2006). However, the higher rate of 
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associated anomalies in our series may also be a consequence of inclusion of referred cases 
with severe anomalies.  
 
Esophageal atresia without fistula, usually with a long gap, is known to be associated with 
trisomy 21 (Ein et al. 1993; Beasley et al. 1997) and the only case with trisomy 21 in our 
study had a long gap atresia. Twenty-five percent (12/48) of the cases with esophageal 
obstruction in the present study also had imperforate anus, but only 1 of these 12 had 
abnormal karyotype (47 XX i(18p)i(18q)). These findings are supported by a large 
epidemiological study (Depaepe et al. 1993) where none of the cases with the combination 
of esophageal atresia and imperforate anus had an abnormal karyotype. This is noteworthy 
since there is a well-known association with imperforate anus, usually without fistula, and 
trisomy 21 (Black and Sherman 1989; Zlotogora et al. 1989; Torres et al. 1998).  
 
Increased nuchal translucency at 11 - 13+6 gestational weeks has been shown in a case with 
isolated esophageal atresia (Brown and Nicolaides 2000). In our study, one case was 
suspected to have a high gastrointestinal anomaly already at 10 weeks’ gestation due to a 
stomach too large for the gestational age. Overdistended stomach at 12 weeks was presented 
in a case with esophageal atresia without fistula but with additional duodenal stenosis 
(Tsukerman et al. 1993). In our case, the physiological herniation may have given a similar 
situation with a transient obstruction distal to the stomach. Normal values of the size of the 
fetal stomach have been described from 8 gestational weeks (Blaas et al. 1995) and in our 
experience, the fetal esophagus is easily visualized at the 11 - 13+6 week scan (Blaas et al. 
1995) (Figure 21). An early scan offered to all pregnant women may improve the prenatal 
detection rate due to the fact that nuchal translucency may be increased and thus trigger a 
more thorough evaluation. The size of the fetal stomach may be abnormal and the normal 
appearance of the fetal esophagus may not be visible. However, these aspects need to be 
studied and evaluated further.  
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Figure 21  
Ultrasound image of the esophagus (hyper 
echoic double-line indicated by the arrow) in a 
fetus at 12 weeks’ gestation (CRL 59 mm). 
 
There may also be a potential for improving the prenatal detection rate of esophageal atresia 
if a third trimester scan were offered to all pregnant women. Most cases detected prenatally 
in this study had clinical signs of polyhydramnios leading to a targeted examination. 
However, polyhydramnios was present in only 29% of ongoing pregnancies without prenatal 
diagnosis of esophageal obstruction. Targeted examination in the third trimester with 
evaluation of fetal swallowing and visualization of the fetal esophagus and possible 
esophageal pouch might improve the detection rate of esophageal obstruction, also in cases 
without polyhydramnios, although there may be some limitations due to acoustic shadowing. 
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SUMMARY 
Background 
Anomalies in the gastrointestinal tract and abdominal wall are relatively common. The 
present studies include the diagnoses of gastroschisis, omphalocele, imperforate anus, 
esophageal and duodenal obstruction. In all these conditions, the newborns are in need of 
postnatal surgery. A prenatal diagnosis may improve the outcome by optimizing the pre- and 
postnatal care for the newborn. Historically, the clinical course has been based on postnatally 
diagnosed cases and, until recently, knowledge has been lacking about the intrauterine 
development and thereby the possibility for optimal surveillance for certain diagnoses. There 
is a wide variety in the accuracy and sensitivity of detecting different anomalies prenatally.  
 
The aims of the studies were 
Selected population 
To describe the outcome from the time of prenatal diagnosis into the postnatal period and 
to identify risk factors for poor outcome and determine whether surveillance may be 
beneficial. An additional aim was to describe the rate of prenatal diagnosis and elucidate 
possible strategies for improved diagnosis.  
 
Non-selected population 
To describe the incidence, prenatal detection rate and accuracy of the diagnoses in our 
non-selected population.  
 
Materials and methods 
The study populations of duodenal obstruction, gastroschisis and omphalocele were 
followed from the time of a prenatal diagnosis, through birth and into the postnatal 
period. The studies of imperforate anus and esophageal obstruction were based on all 
cases that had been through at least one prenatal ultrasound examination at the National 
Center for Fetal Medicine at any time during pregnancy and been given the diagnosis 
either pre- or postnatally.  
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All studies were based on a selected population consisting of referred cases in addition to 
our own non-selected population. The non-selected population was also investigated 
separately.  
 
Results and comments 
Duodenal obstruction 
The study comprised 29 prenatally diagnosed fetuses. Trisomy 21 was present in 21%. 
Altogether, associated anomalies were present in 18/29 (62%). Isolated duodenal 
obstruction, with an expected good outcome, was present in 11/29 (38%). Of these, 5/11 
(45%) died in utero or had a substantially impaired neurological development most 
probably due to intrauterine asphyxia. Our hypothesis is that a vagal overactivity due to 
distension in the lower esohageal tract leads to bradycardia, asphyxia and in some cases 
even asystolia and death. Fetal duodenal obstruction is a serious condition with a high 
risk of adverse outcome, also in cases with normal karyotype and no other anomalies. 
Surveillance of fetuses with duodenal obstruction is difficult because the fatalities seem 
to occur instantly. The prenatal detection rate in the non-selected population was high 
(82%). The incidence was approximately 1:3500. There was one false positive case. 
 
Gastroschisis 
Sixty-four fetuses with a prenatal diagnosis of gastroschisis were included. All cases had 
normal karyotype. Associated anomalies were present in 6%. Thirteen infants (22%) were 
small for gestational age. Prenatal intra-abdominal dilatation of the bowel was associated 
with obstruction of the bowel. Pathological CTG indicating fetal distress and leading to 
emergency CS developed in 22% of the fetuses already prior to labor. Intensive CTG 
monitoring of fetuses with gastroschisis in the third trimester may reduce the risk for fetal 
distress and IUFD. Of the 64 cases, 56 (87.5%) survived and all had a life without any 
significant gastrointestinal problems at follow-up over a period of 6-180 months. The 
prenatal detection rate in the non-selected population was 100% and there were no false 
positive cases. The incidence was 1:2290. 
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Omphalocele 
The outcome of 90 fetal cases with omphalocele was poor with only 8 (9%) infants alive 
and healthy. The rate of associated anomalies was high (89%). Omphaloceles were 
subdivided into epigastric, central and hypogastric based on the location of the defect. 
The fact that abnormal karyotype was present in 69% of fetuses with central 
omphaloceles compared to 13% of fetuses with epigastric omphaloceles (P < 0.0001) 
leads us to consider the possibility that central and epigastric omphaloceles are different 
entities. When a thorough diagnosis was made, it was possible to identify a subgroup 
with fatal/poor prognosis. Surveillance should be focused on those whose prognosis is 
believed to be good. In the non-selected population the prenatal detection rate was 95% 
and there were no false positive cases. The incidence was 1:2000. 
 
Imperforate anus 
The study comprised 69 cases with imperforate anus. The prenatal detection rate was low 
(16%). Abnormal karyotype was present in 13%. Altogether, associated anomalies were 
frequent (86%) and imperforate anus was commonly a part of various syndromes. The 
outcome was poor with only 35% survival; survival for cases with isolated imperforate anus 
or only one additional anomaly was 94%, compared to only 14% for cases with more than 
one additional anomaly. The future detection rate may be improved by heightened awareness 
of the condition and of the type of anomalies commonly seen with imperforate anus in 
addition to the ability to recognize the most typical ultrasound findings in imperforate anus. 
In the non-selected population, the incidence was approximately 1:1800; a prenatal diagnosis 
was made in 11% and there were no false positive cases. 
 
Esophageal obstruction 
Forty-eight cases with esophageal obstruction were investigated and the prenatal detection 
rate was 21/48 (44%). The clinical signs of polyhydramnios were the most important factors 
for prenatal detection of esophageal obstruction. Consequently, the time of diagnosis was 
late (median 32+0 weeks). In all prenatally diagnosed cases, the stomach was small or not 
visible. In addition, an esophageal proximal pouch was visualized in 9/21 (43%) of the cases. 
Of all 48 cases, abnormal karyotype was present in 23%. Altogether 38/48 (79%) had 
 74 
associated anomalies. Survival was higher, but not significantly, for cases with isolated 
esophageal obstruction. An increased awareness of the possibility of esophageal obstruction 
leading to targeted examinations whenever the suspicion is raised during pregnancy might 
improve the prenatal detection rate and thereby the outcome. In the non-selected population, 
the incidence was approximately 1:3500, the prenatal detection rate was 43% and there were 
no false positive cases. 
 
Conclusion 
For all the investigated diagnoses, the accuracy of the prenatal diagnoses was high. The 
prenatal detection rate in the non-selected population was high for cases with duodenal 
obstruction (82%), gastroschisis (100%) and omphalocele (95%) while the detection rate 
for esophageal obstruction was relatively low (43%) and for imperforate anus very low 
(11%). Fetal populations are different from neonatal populations. It is important to rule 
out cases with lethal associated anomalies. Adequate surveillance of the remaining cases 
gives a possibility to improve the outcome. The surveillance at our center has 
substantially changed for cases with duodenal obstruction and gastroschisis as a direct 
consequence of these studies. Knowledge of the development during intrauterine life 
must be further improved to be able to optimize the surveillance and care for fetuses with 
various anomalies.  
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FUTURE ASPECTS 
Our aim is to provide a better start for the newborn individual through identifying fetal 
disease and treating the problem. The most attractive scenario concerning fetal anomalies 
would be the prevention of occurrence. The increased knowledge in biotechnology and 
molecular genetics might make that possible for some of the anomalies. A number of 
anomalies are now mapped genetically and for an increasing number of anomalies we 
have possibilities for early DNA diagnosis. For families with hereditary conditions, this 
may reduce their anxiety regarding their pregnancies. However, we will continue to be 
faced with the unexpected diagnosis of fetal anomalies. A correct, detailed prenatal 
primary diagnosis and the ability to rule out associated diagnoses will therefore still be 
the basis for treatment and surveillance. Fetal diagnoses may be made earlier and earlier 
as ultrasound becomes more widespread and offered to more women earlier in pregnancy. 
In addition, the technology is constantly improving and the 3D ultrasound technique and 
MRI may be valuable in some cases, complementary to 2D ultrasound. However, if 
women are to be able to benefit from increased use of prenatal diagnosis we must have 
the knowledge and skills to offer high quality examinations.  
 
Information and counseling will be of even more importance with earlier diagnoses and 
easier access for termination of pregnancy. In this context, the socioeconomic situation in 
the country and the availability of health care for different conditions will play a role.   
 
In cases of diagnosis of a fatal condition, the knowledge and information to parents will 
be of increasing importance. To dare to become pregnant again, knowing about risks and 
possibilities is important for the woman’s/parents’ psychological wellbeing.  
 
Fetal medicine is still in an early phase of development and extensive future research is 
needed to determine how to best diagnose and treat the fetus. 
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CORRECTIONS 
 
Paper II  
Page 5, Methods, line 9 
“from January 1988 to August 2000”  
Should be: “from January 1988 to August 2002”. 
 
In references 
Reference 54.  
“Tunon K, Eik-Nes SH, Grottum PA. comparison between ultrasound and a reliable last 
menstrual period as predictors of the day of delivery in 15,000 examinations. Ultrasound 
Obstet Gynecol. 1996 Sep;8(3): 178-85.”  
Should be: “Tunon K, Eik-Nes SH, Grottum P. A comparison between ultrasound and a 
reliable last menstrual period as predictors of the day of delivery in 15,000 examinations. 
Ultrasound Obstet Gynecol. 1996 Sep;8(3): 178-85.” 
 
Paper III 
Page 530, Figure 2, line 2 
“Mean birth weight 2475 (range, 830-3964) g, mean gestational age 35+3 (range, 27+2 
to 39+2) weeks.”  
Should be at the bottom line referring to the 24 infants with normal karyotype, not 
Beckwith-Wiedemann.  
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